• Home
  • Symposia
    • San Diego Dermatology Symposium
    • Dermatology Refresher Symposium for NPs and PAs
    • Dermatology Innovation Symposium
    • Dermatology Therapeutics Symposium
  • Archives
  • Contact Us
Dermatology Research and Education Foundation
Picture
Sergei Grando, MD, PhD
Curriculum Vitae  

Name: Sergei Alexander Grando, M.D., Ph.D., D.Sc. 

Title: Distinguished Professor at University of California Irvine 

Office: Department of Dermatology, University of California Irvine, Medical Surge II, Room 362, Irvine, CA 92697, USA.  Telephone: (949) 824-2713; Fax: (949) 824-2993. 

Email: sgrando@uci.edu 

Home: 15507 Orchid Avenue, Tustin, California 92782, USA.  
Telephone: (949) 552-4211; Fax: (949) 552-4311 

I.  VITAE                
Birth date:
February 14, 1957

Birthplace:
Kyiv, Ukraine

Citizenship
USA

 
Professional Degrees:
Institute and Location
Degree
Year Conferred
Field of Study

Medical Institute, Kyiv, Ukraine
M.D.
1980
Medicine

PostGraduate Institute for Physicians, Kyiv, Ukraine
Ph.D.
1984
Pharmacology and Biochemistry

Central Institute of Dermatology and
Venereology, Moscow, Russia
D.Sc.
(Doctor of Science in Medicine)
1989
Immunology and
Cell Biology

 
Academic Appointments:
2007-present
Professor (tenured; current Step: Above Scale), Departments of Dermatology (primary), and Biological Chemistry (secondary), University of California Irvine

1996-2007
Professor of Dermatology (tenured), Department of Dermatology, University of California Davis

1992-1996
Associate Professor of Dermatology (tenured), Department of Dermatology, University of Minnesota,

1991-1992
Visiting Professor, Department of Dermatology, University of Minnesota

 
1990-1991
Professor of Dermato-venereology and Immunology, Department of Dermatology and Venereology, PostGraduate Institute for Physicians, Kyiv, Ukraine

1989-1990
Acting Professor, Department of Dermatology and Venereology, PostGraduate Institute for Physicians, Kyiv, Ukraine

1985-1989
Assistant Professor, Department of Dermatology and Venereology, PostGraduate Institute for Physicians, Kyiv, Ukraine

1984-1985
Instructor of Dermatology and Venereology, Department of Dermatology and Venereology, PostGraduate Institute for Physicians, Kyiv, Ukraine

 
 
Postgraduate Medical Training in Ukraine and Re-training in USA:
1996-1999
American Dermatologic Residency Experience Fulfilling the American Board of Dermatology Certification Requirements, Department of Dermatology, University of California Davis School of Medicine, Davis

1995-1996
Transitional Year Residency Program at Hennepin County Medical Center, Minneapolis, Minnesota

1980-1982
Resident in Dermatology, Department of Dermatology and Venereology, PostGraduate Institute for Physicians, Kyiv, Ukraine

1979-1980
Intern in General Medicine, Medical Institute, Kyiv, Ukraine

 
Research Fellowships:
1984-1989
The D.Sc. (i.e., Doctor of Sciences in Medicine) Program of the Central Institute of Dermatology and Venereology (Moscow, Russia) at Kyiv State University: Departments of Biochemistry, Molecular and Cellular Biology, and Immunology

1982-1984
The Ph.D. (i.e., Candidate of Sciences in Medicine) Program at PostGraduate Institute for Physicians, Kyiv, Ukraine:  Departments of Dermatology and Venereology, Pharmacological Chemistry, and Drug Development

 
Certification/Licensure:
1999
Diplomate, American Board of Dermatology (re-certified in 2009 and 2019)

1996
Licensed, Medical Board of California

1996
Licensed, Minnesota Board of Medical Practice

1995
Certified, Educational Commission for Foreign Medical Graduates, USA

1991
Certified, Highest Qualifications in Dermatology, Venereology, and Clinical and Laboratory Immunology, the USSR Ministry of Health

1982
Certified in Dermatology and Venereology by the USSR Ministry of Health

 
Honors:
2017
Honorary Member, the French Society of Dermatology

2017
America's Most Honored Professionals 2017 - Top 5%

2016
Best of Irvine Award

2016
Featured in Orange Coast Magazine among Top Doctors chosen by their peers

2015, 2016, 2017
Recognized among Castle Connolly Top Doctor for Irvine, CA

 
2013-2018
Vice Chair for Research, Department of Dermatology, UC Irvine
 

 
since 2013
Included in Best Doctors in America database
 

 
since 2012
HealthGrades Recognized Doctor
 

 
2010
Doctor of the Year, International Pemphigus and Pemphigoid Foundation, USA
 

1999-2007
Founder, International Pemphigus Research Fund (IPRF)

1996-2007
Member, Graduate Group in Immunology, University of California Davis

2000-present
Former Vice Chair and current member, Medical Advisory Board of International Pemphigus and Pemphigoid Foundation

2004
Honorary Chair for California, NRCC Physicians' Advisory Board

2003
Vice Chair, Dermatology Foundation of California

2002
Honorary Member, Ukrainian Association of Dermatologists, Venereologists, Cosmetologists, Ukraine
 

1995
FIRST Award, NIH, NIAMS, USA

1991
Honorary Member, Belgian Royal Society of Dermatology and Venereology, Belgium

1981, 1982, 1983, 1984, 1985, 1986, 1987, 1988
Annual Award for the Best Scientific Presentation among Young Investigators, PostGraduate Institute for Physicians, Kyiv, Ukraine

1987
Award, Municipal Society for Scientists and Specialists, Kyiv, Ukraine

1988
Premium, Ukrainian Republican Society for Inventors, Kyiv, Ukraine

 
Other Positions:
2021-present
2021-present
Member, Research Award Nominations Committee, UC Irvine
Director, The Immunobullous Clinic, UC Irvine Department of Dermatology
 

2016-2018
Representative, College of Health Sciences Academic Senate, UC Irvine
 

2016-present
Clinical Advisor, American Academy of Dermatology, Burden of Skin Disease Work Group
 

2011-present
Member and Ad Hoc Chair, Academic Resources Advisory Committee, UC Irvine
 

2009-2012
Member, Divisional Senate Assembly, UC Irvine
 

2009-2013
Member, Promotions & Honors Exec. Committee of the Academic Senate, UC Irvine
 

2007-present
Faculty affiliate, UC Irvine Cancer Research Institute
 

2007-present
Faculty member, UC Irvine Cancer Center
 

2007-present
Faculty member, UC Irvine Institute for Immunology
 

2007-2015
Director, CME Program, UC Irvine Department of Dermatology
 

2005-2007
Faculty member, UC Davis Cancer Center
 

2004-2005
Member, Compensation Advisory Committee, UC Davis, School of Medicine

2001-2002
Member, Executive Committee, UC Davis Graduate Group in Immunology
 

2001-2007
Member, Admission Committee, UC Davis Graduate Group in Comparative Pathology

2000-2007
Faculty member, UC Davis Center of Neuroscience
 

2000-2001
Senior Consultant, Psoriasis Research Institute
 

1998-present
Member (former Vice Chair), Medical Advisory Board of the International Pemphigus and Pemphigoid Foundation
 

1999-2007
Member, Graduate Group in Comparative Pathology, University of California Davis
 

 
1996-2007
Director, Research Laboratories, Department of Dermatology, University of California Davis

1995-1996
Director, Research Laboratories, Department of Dermatology, University of Minnesota

 
1994 - 1995
Member, the University of Minnesota Committee on the Use Of Human Subjects in Research, Minneapolis, Minnesota

1989 - 1991
Director, Medical and Biological Division of Scientific and Industrial Cooperative "Technobascom", Kyiv, Ukraine

1989 - 1991
Dean, Office of International Relations of PostGraduate Institute for Physicians, Kyiv, Ukraine,

1989 - 1991
Member, Scientific Council of Kyiv PostGraduate Institute for Physicians, Ukraine

1988 - 1991
Member, Scientific Council on Clinical and Experimental Immunology, the Ukr.SSR Academy of Sciences of Health, Kyiv, Ukraine,

 
1986 - 1991
Chief, Unit of Immunodermatology and Extracorporeal Detoxification, Central Dermato-Venereologic Hospital, Kyiv, Ukraine

1986 - 1987
Member, Advisory Committee on Liquidation of Medical and Biological Consequences of Chernobyl Disaster, the Ukr.SSR Ministry of Health, Ukraine

1978 - 1980
Chairman, the Academician Kissel Students' Scientific Society of Kyiv Medical Institute, Ukraine

 
Meeting Organizer/Chairman
2019
Organizer, The 5th Intl. Conference on Nonneuronal Acetylcholine, Long Beach, CA
 

2017
Co-organizer, Scientific Meeting of International Pemphigus and Pemphigoid Foundation, Luebeck, Germany
 

2017
Co-organizer, Annual Meeting of International Pemphigus and Pemphigoid Foundation, Newport Beach, CA

2014
Co-organizer, The 4th Intl. Conference on Nonneuronal Acetylcholine, Giessen, Germany

2013
Member of Organizing Committee, The 2nd International Conference on Clinical & Cellular Immunology, Las Vegas, NV

2011
Co-organizer, The 3rd Intl. Conference on Nonneuronal Acetylcholine, Groningen, Holland

2011
Co-chairman, The 22nd World Congress of Dermatology, Seoul, South Korea

2010
Organizer, "Pemphigus & Pemphigoid: from the bench to the bedside," NIH, Bethesda, MD

2006
Co-chairman, Organizing Committee of the 2nd International Symposium on Nonneuronal Acetylcholine, Mainz, Germany
 

2005
Co-organizer, "Pemphigus 2005 - Progress and Future Directions," NIH, Bethesda, MD
 

2002
Chairman, Organizing Committee of the 1st International Symposium on Nonneuronal Acetylcholine, San Francisco, CA
 

 
Invited Speaker/Guest Lecturer/Visiting Professor:
2022
Department of Dermatology, University of New Mexico, Albuquerque, NM
 

2022
California Dermatology Physician Assistant Society Symposium, Costa Mesa, CA
 

2022
Department of Dermatology, University of California Los Angeles, CA
 

2022
International Pemphigus & Pemphigoid Foundation Virtual Patient Education Conference.
 

2022
San Diego Dermatology Symposium, San Diego, CA
 

2021
International Pemphigus & Pemphigoid Foundation, Scientific Symposium, Marburg, Germany
 

2020
International Pemphigus & Pemphigoid Foundation Virtual Patient Education Conference.
 

2020
San Diego Dermatology Symposium, San Diego, CA
 

2020
Department of Dermatology & Cutaneous Surgery, University of Miami, Miami, FL
 

2019
The 8th Annual Immunoglobulin Nursing Society National Convention, Las Vegas, NV
 

2019
The 77th Annual Meeting of American Academy of Dermatology, Washington, DC
 

2019
Division of Dermatology, University of Texas Health San Antonio, TX
 

2019
Department of Dermatology, University of Illinois at Chicago, IL
 

2018
Department of Dermatology, University of Minnesota, Minneapolis, MN
 

2018
Department of Dermatology, Mayo Clinic, Scottsdale, AZ
 

2018
The 40th Annual Academician O.O. Bogomolets Seminar, National Medical University, Kyiv, Ukraine
 

2018
The 11th International Congress on Autoimmunity, Lisbon, Portugal

2018
Neurotransmitters: non-neuronal functions and therapeutic opportunities, Orleans, France
 

2018
Department of Dermatology, University of Arkansas, Little Rock, AR
 

2017
Annual Meeting of International Pemphigus and Pemphigoid Foundation, Newport Beach, CA
 

2017
Department of Dermatology, University of California San Diego, CA
 

2017
Department of Dermatology, The Mount Sinai Hospital, New York, NY
 

2017
Scientific Meeting of International Pemphigus and Pemphigoid Foundation, Luebeck, Germany
 

2017
The 75th Annual Meeting of American Academy of Dermatology, Orlando, FL
 

2016
Department of Dermatology, Wayne State University, Detroit, MI
 

2016
Pathogenesis of Pemphigus and Pemphigoid, Munich, Germany
 

2016
Annual Meeting of International Pemphigus and Pemphigoid Foundation, Austin, TX
 

2016
Department of Dermatology, Henry Ford Medical Center, Detroit, MI
 

2016
The 17th World Conference on Lung Cancer, Vienna, Austria
 

2016
The 10th International Congress on Autoimmunity, Leipzig, Germany
 

2016
The 15th International Symposium on Cholinergic Mechanisms, Marseille, France
 

2016
Department of Dermatology, Georgetown University, Washington, DC
 

2016
Department of Dermatology, University of Illinois at Chicago, IL
 

2016
6th Summit in Aesthetic Medicine, Newport Beach, CA
 

2015
Houston Dermatology Society Meeting, Houston, TX
 

2015
The 73rd Annual Meeting of American Academy of Dermatology, San Francisco, CA
 

2015
The 4th Annual Immunoglobulin Nursing Society National Convention, Washington, DC
 

2015
Annual Meeting of International Pemphigus and Pemphigoid Foundation, New York, NY
 

2015
Department of Dermatology, Stanford University, Palo Alto, CA
 

2015
Department of Dermatology, The Mount Sinai Hospital, New York, NY

2014
The 4th Annual Meeting of Euro-Asian Assoc. of Dermato-venereologists, Jerusalem, Israel
 

2014
Department of Dermatology, Rutgers New Jersey Medical School, Newark, NJ

2014
Annual Meeting of International Pemphigus and Pemphigoid Foundation, Chicago, IL

2014
Department of Dermatology, University of Minnesota, Minneapolis, MN

2014
4th Summit in Aesthetic Medicine, Dana Point, CA

2014
The 4th Intl. Conference on Nonneuronal Acetylcholine, Giessen, Germany

2014
The 9th International Congress on Autoimmunity, Nice, France

2014
Department of Dermatology, St. Louis University, St. Louis, MO

2014
The 26th Annual Meeting of Wound Healing Society, Orlando, FL

2014
The 72nd Annual Meeting of American Academy of Dermatology, Denver, CO

2014
The Florida West Coast Society of Dermatology and Department of Dermatology & Cutaneous Surgery of University of South Florida, Tampa, FL

2014
2nd International Symposium on Dermato-endocrinology, Copenhagen, Denmark

2013
Department of Dermatology, University of Arizona, Tucson, AZ

2013
The Miami Society for Dermatology and Cutaneous Surgery, Miami, FL

2013
The 2nd International Conference on Clinical & Cellular Immunology, Las Vegas, NV

2013
Investigator Sponsored Research Forum, Grifols, Raleigh, NC

2013
XI International Congress of Dermatology, New Delhi, India

2013
1st International Symposium on Dermato-endocrinology, Edinburgh, UK

2013
The Dermatology Nurse Practitioner Society of New England, Boston, MA
 

2013
Annual Meeting of International Pemphigus and Pemphigoid Foundation, San Francisco, CA
 

2013
30th Annual Conference of the Egyptian Society of Dermatology & Venerology, Cairo, Egypt
 

2013
International Symposium on Autoimmune Bullous Diseases, Lübeck, Germany
 

2013
The 71st Annual Meeting of American Academy of Dermatology, Miami, FL
 

2013
Department of Dermatology, Kaiser Permanente Medical Center, Los Angeles, CA
 

2012
The 3rd Continental Congress of Dermatology, Durban, South Africa
 

2012
The 13th  Las Vegas Dermatology Seminar, Las Vegas, NV
 

2012
"Modulation of Autoimmunity" Retreat, Lübeck, Germany
 

2012
Summer American Academy of Dermatology Meeting, Boston, MA
 

2012
Annual Meeting of the European Society for Dermatological Research, Venice, Italy
 

2012
The 8th International Congress on Autoimmunity, Granada, Spain
 

2012
Annual Meeting of the International Pemphigus and Pemphigoid Foundation, Boston, MA
 

2012
The 70th Annual Meeting of American Academy of Dermatology, San Diego, CA
 

2011
Loma Linda University Medical Center, Loma Linda, CA
 

2011
The 20th Prof. Dr. A. Lufty Tat Symposium, Ankara, Turkey
 

2011
Summer American Academy of Dermatology Meeting, New York, NY
 

2011
Department of Dermatology, UCLA-Harbor Medical Center, Los Angeles, CA
 

2011
International von Behring-Röntgen Symposium “Pemphigus – from autoimmunity to disease”, Marburg, Germany
 

2011
The 3rd International Conference on Drug Discovery & Therapy, Dubai, U.A.E.
 

2011
Institute for Anatomy and Cell Biology, Justus-Liebig-University, Giessen, Germany
 

2011
The 9th Anti-Aging Medicine World Congress & MediSpa, Monte-Carlo, Monaco
 

2011
Wellcome Trust Scientific Conference, Hinxton, UK
 

2011
The 69th Annual Meeting of American Academy of Dermatology, New Orleans, LA
 

2010
The 9th Ukrainian Congress of Dermatologists and Venereologists, Odessa, Ukraine
 

2011
The 3rd Intl. Conference on Nonneuronal Acetylcholine, Groningen, Holland
 

2011
The 22nd World Congress of Dermatology, Seoul, South Korea
 

2010
Summer American Academy of Dermatology Meeting, Chicago, IL
 

2010
The 13th World Congress on Cancers of the Skin, Madrid, Spain
 

2010
"Pemphigus & Pemphigoid: from the bench to the bedside," NIH, Bethesda, MD
 

2010
The 68th Annual Meeting of American Academy of Dermatology, Miami, FL
 

2009
Loma Linda University Medical Center, Loma Linda, CA
 

2009
The Scientific Conference Dedicated to the 125th Anniversary of Dept. of Dermatology of National O. O. Bohomolets Medical University, Kyiv, Ukraine
 

2009
International Pemphigus Meeting, Berne, Switzerland
 

2009
The 10th International Congress of Dermatology, Prague, Czech Republic
 

2009
The 67th Annual Meeting of American Academy of Dermatology, San Francisco, CA
 

2009
The 15th Conference of the Panamerican Society for Pigment Cell Research, Memphis, TN
 

2008
The 7th Annual Meeting of Flight Attendant Medical Research Institute, Boston, MA
 

2008
Environmental Stressors in Biology and Medicine, Siena, Italy
 

2008
The 66th Annual Meeting of American Academy of Dermatology, San Antonio, TX
 

2008
International Meeting on Autoimmune Bullous Diseases, Otsu, Japan
 

2008
Recent Advances in Muscarinic Receptor Pharmacology and Therapeutics, San Diego, CA
 

2007
The 21st World Congress of Dermatology, Buenos Aires, Argentina
 

2007
Frontiers of Cutaneous Biology, Greifswald, Germany
 

2007
The 6th Annual Meeting of Flight Attendant Medical Research Institute, Miami, FL
 

2007
Mini-Conference "New Horizons in Biological Roles of Acetylcholine", Tokyo, Japan
 

2007
The 6th Annual Meeting of Flight Attendant Medical Research Institute, Miami, FL
 

2007
The 80th Annual Meeting of the Japanese Pharmacological Society, Nagoya, Japan
 

2007
The 65th Annual Meeting of American Academy of Dermatology, Washington, D.C.
 

2006
Research seminar at Athenagen, Inc., Palo Alto, CA
 

2006
Pemphigus/Pemphigoid Satellite Symposium, Annual ESDR Meeting, Paris, France
 

2006
The 5th Annual Meeting of Flight Attendant Medical Research Institute, Boston, MA
 

2006
National Academy of Science of Ukraine, Palladin Institute of Biochemistry, Kyiv, Ukraine
 

2006
The Unilever Research-U.S.A., Edgewater, NJ
 

2006
The 5th Annual Meeting of Flight Attendant Medical Research Institute, Boston, MA
 

2006
Department of Dermatology, University of Southern California, Los Angeles, CA
 

2006
Department of Dermatology, University of Luebeck, Luebeck, Germany
 

2006
The 2nd International Symposium on Nonneuronal Acetylcholine, Mainz, Germany
 

2006
The 64rd Annual Meeting of American Academy of Dermatology, San Francisco, CA
 

2005
The Unilever Research-USA, Edgewater, NJ
 

2006
Frontiers of Cutaneous Biology, Bradford, UK
 

2005
Department of Dermatology, Harbor-UCLA Medical Center, Los Angeles, CA
 

2005
The 14th Congress of European Academy of Dermatology and Venereology, London, UK
 

2005
The 8th Ukrainian Congress of Dermatologists and Venereologists, Kyiv, Ukraine
 

2005
The 4th Annual Meeting of Flight Attendant Medical Research Institute, Miami, FL
 

2005
Department of Dermatology, University of California-Irvine, CA
 

2005
"Pemphigus 2005 - Progress and Future Directions," NIH, Bethesda, MD
 

2004
The 10th Anniversary Meeting of Gifu Dermatology Research Seminars, Gifu, Japan
 

2004
Bradford Club 2004, University of Bradford, UK
 

2004
Ukrainian Association of Dermatologists, Venereologists & Cosmetologists, Kyiv, Ukraine
 

2004
The 3rd Annual Meeting of Flight Attendant Medical Research Institute, Miami, FL
 

2004
Research seminar at Avon Products, Inc. Suffern, NY.
 

2004
First Vitiligo Researcher Conference, American Vitiligo Res. Foundation, Clearwater, FL
 

2004
The 25th Colombian National Dermatology Congress, Bogotá, Colombia.
 

2004
The International Pemphigus Foundation Meeting in Las Vegas, NV
 

2004
The 62nd Annual Meeting of American Academy of Dermatology, Washington, D.C.
 

2004
The Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL
 

2004
International Scientific Congress "Neurobiology of the Skin," Muenster, Germany
 

2004
Research conference "IVIg Treatment of Pemphigus", Bethesda, MD
 

2003
International Conference on Oxidative Stress in Skin Biology and Medicine, Andros, Greece
 

2003
The 2nd Annual Meeting of Flight Attendant Medical Research Institute, Miami, FL
 

2003
Symposium "Frontiers in Cutaneous Biology in 2003," Bradford, UK
 

2003
Department of Dermatology, USC and Westwood VA, Los Angeles, CA
 

2003
Department of Dermatology, Gifu University Medical School, Gifu, Japan
 

2003
German Armed Forces Institute of Pharmacology and Toxicology, Munich, Germany
 

2003
Department of Pharmacology, University of Pennsylvania, Philadelphia, PA
 

2003
The 61st Annual Meeting of American Academy of Dermatology: San Francisco, CA
 

2003
Association for Proficiency in Skin Immunology, San Francisco, CA
 

2003
Skin Disease Education Foundation: Hawaii Dermatology Seminar, Maui, HI
 

2003
Department of Dermatology, University of California-Irvine, CA
 

2002
The 1st International Symposium on Nonneuronal Acetylcholine, San Francisco, CA
 

2002
Autoimmunity and the Skin (51st Montagna Symposium on Skin Biology), Snowmass, CO
 

2002
Medical Meeting of Flight Attendant Medical Research Institute, Miami, FL
 

2002
International Workshop on Cutaneous Neuroendocrinology, Hamburg, Germany
 

2002
International Meeting on Bullous Dermatoses, Groningen, The Netherlands
 

2002
The Unilever Research-USA, Edgewater, NJ
 

2002
Department of Dermatology, The Mount Sinai Hospital, New York, NY
 

2001
Irvin H. Blank Resident/Fellow Forum; 62nd SID Annual Meeting, Washington, D.C.
 

2002
Department of Dermatology, University of Miami School of Medicine, Miami, FL
 

2002
The 60th Annual Meeting of American Academy of Dermatology, New Orleans, LA
 

2002
International Pemphigus Foundation, Anaheim, CA
 

2001
Pemphigus as a Model of Organ-specific Autoimmune Disease, NIH, Bethesda, MD
 

2001
Department of Dermatology, UT Southwestern Medical Center, Dallas, TX
 

2000
Pemphigus'2000, Bangkok, Thailand
 

2000
Department of Dermatology, University of California-San Diego, CA
 

2000
Psoriasis Research Institute, Palo Alto, CA
 

2000
International Pemphigus Foundation, San Francisco, CA
 

1999
The Unilever Research-USA, Edgewater, NJ
 

1998
Symposium on Hereditary and Acquired Bullous Dermatoses, Salzburg, Austria
 

1998
Department of Dermatology, University of California-San Francisco, CA
 

1997
The 19th World Congress of Dermatology, Sydney, Australia
 

1996
The Cutaneous Biology Foundation, Inc, USA
 

1996
Department of Dermatology, Mayo Foundation and Clinics, Rochester, MN
 

1995
University of Texas Medical Branch, Galveston, TX
 

1993
Department of Pharmacology and Exp. Therapeutics, Univ. of Maryland, Baltimore, MD
 

1993
Department of Biochemistry, University of Minnesota, St. Paul, MN
 

1991
Belgian Royal Society of Dermatology and Venereology, Liege, Belgium
 

1991
Louis Pasteur University, Strasbourg, France
 

1990
Department of Dermatology at University of Southampton, UK
 

1990
Department of Dermatology at Royal Hallamshire Hospital, Sheffield, UK
 

1990
Department of Dermatology at Slade Hospital, Oxford, UK
 

1990
St John's Institute of Dermatology, London, UK
 

1990
Italian Society for Dermatology and Venereology, Venice, Italy
 

1989
Department of Immunology, Innsbruck University, Austria
 

1989
Department of Dermatology, University of Vienna, Austria
 

 
 
 

 
Editor/Editorial Board Member
 
2021 - present
2020
Editorial Board: Immunologic Research
Guest Editor, International Immunopharmacology
 

2017 – present
Associate Editor of Dermatology, Frontiers in Medicine

2015
Guest Editor, International Immunopharmacology
 

2012 - present
Editorial Board, American Journal of Clinical and Experimental Immunology
 

2012
Guest Editor, Life Sciences
 

2011
Guest Editor, Monographic issue of Autoimmunity on Immunoblistering Dermatoses
 

2010 - 2021
Section Editor: Autoimmunity Highlights
 

2010 - present
Editorial Board: Experimental Dermatology
 

2009 - present
Editorial Board, Dermatology Reports
 

2009 - present
Editorial Board, Journal of Experimental Pharmacology
 

2007
Guest Editor, Life Sciences
 

2006
Guest Editor, Monographic issue of Autoimmunity on Pemphigus
 

2003
Guest Editor, Life Sciences
 

2003 – 2016
Editorial Consultant, Physicians' Information and Education Resource, American College of Physicians, Philadelphia, PA
 

2002 – present
Editorial Board, Frontiers in Bioscience
 

2001 – present
Editorial Board, Ukrainian Journal of Dermatology, Venereology, Cosmetology
 

1990 - 1991
Editorial Board, Problems in Dermatologic Diagnosis & Management, Newark, NJ,
 

1989 - 1992
Editorial Board, International Journal of Dermatology
 

 
Research Grant Reviewer:
2014 – present
Research Grant Reviewer, Deutschen Forschungsgemeinschaft (DFG), Germany

2010 – 2012
Research Grant Reviewer, Kentucky Lung Cancer Res. Program, Louisville, KY

2010 – present
Research Grant Reviewer, The Wellcome Trust, UK

2009 – present
Research Grant Reviewer, U.S. - Israel Binational Science Foundation

2009 – 2012
External Referee, British Skin Foundation, London, UK

2005 – 2010
Research Grant Reviewer, LYTMOS Group, LLC

2004 – 2006
Reviewer, Institute For Science and Health, St. Louis, MO

2004 – present
Ad Hoc Reviewer or Chairperson, Center for Scientific Review, NIH, Bethesda, MD

2003 – 2006
Panel Reviewer, The Philip Morris External Research Program

2003 – 2017
Research Grant Reviewer, The American Institute of Biological Sciences

2003 – present
Research Grant Reviewer, Israel Science Foundation

2001 – 2018
Expert Reviewer, National Science Foundation, Washington, D.C.

 
Manuscript Reviewer:
Since year
Name of Journal

2022
2022
2022
BBA Advances
International Journal of Molecular Sciences
 
Apoptosis

2021
Frontiers in Medicine

2018
Frontiers in Immunology

2017
Scientific Reports

2016
Expert Opinion On Drug Discovery

2015
Environmental Toxicology and Pharmacology

2015
Expert Review of Clinical Pharmacology

2015
Lung

2013
Psychoneuroendocrinology

2013
JAMA Dermatology

2013
Journal of Biological Chemistry

2013
Systems Biology of Oxidative Stress

2013
Cancer Research

2013
PLoS ONE

2011
Amino Acids

2011
Dermatology Reports

2013
Acta Dermato-Venereologica

2012
Endocrine Reviews

2012
Journal of Anti-cancer Agents in Medical Chemistry

2010
Toxicology Letters

2010
Expert Review of Clinical Immunology

2010
Human Pathology

2010
Mediators of Inflammation

2010
Gerontology

2009
Current Cancer Drug Targets

2009
Lung Cancer

2009
Cellular and Molecular Life Sciences

2009
Expert Review of Dermatology

2009
Neuroscience

2009
Journal of Neuroscience Research

2008
Nature Reviews Cancer

2008
Cell Calcium

2008
Journal of Clinical Immunology

2008
International Journal of Cancer

2008
Journal of Cellular and Molecular Medicine

2008
 Current Opinion in Investigational Drugs

2008
 Proceedings of the National Academy of Sciences of the U.S.A.

2007
 Trends in Pharmacological Sciences

2007
 The International Journal of Biochemistry &Cell Biology

2007
 American Journal of Clinical Dermatology

2006
 New England Journal of Medicine

2006
 Archives of Oral Biology

2006
 Journal of Drugs in Dermatology

2006
Initial Reviewer, Abstracts for the 67th SID Meeting, Philadelphia, PA

2005
 Clinical and Experimental Dermatology

2005
 British Journal of Pharmacology

2005
 Photochemistry and Photobiology

2005
 Indian Journal of Dermatology, Venereology and Leprology

2005
 Journal of Oral Pathology & Medicine

2005
 Biology of the Cell

2004
 International Journal of Immunopharmacology

2004
 American Journal of Physiology

2004
 Respiratory Research

2004
 Journal of Dermatological Science

2004
 European Journal of Biochemistry

2004
 Archives of Dermatological Research

2004
 Gene

2003
 Journal of Autoimmunity

2003
 Physiological Reviews

2003
 Dermatology Online Journal

2003
 International Immunology

2003
 Laboratory Investigations

2003
 Journal of Neuroimmunology

2002
 Journal of Cellular Physiology

2002
 Life Sciences

2002
 Journal of Clinical Endocrinology & Metabolism

2002
 Clinical and Experimental Immunology

2001
 Clinical Immunology

2001
 FASEB Journal

2001
 Oncogene

2001
 Journal of Neuroscience

2001
 FEBS Letters

2001
 Experimental Dermatology

2001
 Dermatology

2001
 International Journal of Dermatology

2000
 Journal of Laboratory and Clinical Medicine

1999
 Journal of Clinical Investigations

1999
 Archives of Dermatology

1999
 American Journal of Pathology

1999
 IN VITRO Cellular and Developmental Biology

1997
 Journal of Investigative Dermatology

1995
 British Journal of Dermatology

1993
 Journal of the American Academy of Dermatology

1992
 Autoimmunity

1992
 Journal of the European Acad of Dermatology and Venereology

 
 
Professional Societies:
2020-present
American Medical Association

2011-present
American Association for Cancer Research

2008-present
Panamerican Society for Pigment Cell Research

2004-present
International Society of Dermatology

2004-present
American College of Physicians

2003-2007
American Society for Biochemistry and Molecular Biology

2001-2015
Medical Dermatology Society

1998-present
Fellow of the American Academy of Dermatology

1996-2007
Sacramento Valley Dermatological Society

1995-present
Ukrainian Medical Association of North America

1993-2018
Dermatology Foundation (Leaders Society)

1993-present
The Society for Investigative Dermatology

1980-present
Ukrainian Association of Dermatologists, Venereologists, Cosmetologists

 
 
Research Funding:
 
As a Principal Investigator (PI):
 
Project duration        Granting agency/Type of Award     Project Title            Amount of the Award

2023
Dysimmune Diseases Foundation
Characterization of the cellular and molecular mechanisms whereby m3 muscarinic acetylcholine receptor controls epidermal structure and function.
$100,000

2022
Dysimmune Diseases Foundation
Elucidation of mechanism of action of autoantibody to m3 muscarinic acetylcholine receptor that predicts disease relapse in pemphigus vulgaris patients treated with the IVIg-containing multidrug protocol
$75,000

2021
Dysimmune Diseases Foundation
Development of a bioassay predicting disease relapse in pemphigus vulgaris patients treated with the IVIg-containing multidrug protocol – The second year extension.
$75,000

2021
Allergan
Evaluation of Allergan compounds in an in vitro model for sebum production with human sebocyte cells (SEB-1).
$124,342

2020
Dysimmune Diseases Foundation
Development of a bioassay predicting disease relapse in pemphigus vulgaris patients treated with the IVIg-containing multidrug protocol
$75,000

2020
Allergan
Evaluation of Allergan compounds in an in vitro model for sebum production with human sebocyte cells (SEB-1).
$113,686

2019
Dysimmune Diseases Foundation
Identification of laboratory parameters predicting the therapeutic response of pemphigus patients to IVIg therapy.
$75,000

2019
Allergan
Fifth extension of proof-of-concept study of inhibition of sebocyte proliferation and lipid synthesis by AGN compounds'
$113,686

2018-2019
Allergan
Fourth extension of proof-of-concept study of inhibition of sebocyte proliferation and lipid synthesis by AGN compounds'
$55,830

2017-2018
Allergan
Third extension of proof-of-concept study of inhibition of sebocyte proliferation and lipid synthesis by anti-cholinergic drugs
 
$85,000

2017-2019
NIH, NCATS/R13
5th International Symposium on Non-neuronal Acetylcholine: From Bench to Bedside
$20,000

2017-2018
Grifols Therapeutics Inc
 
Retrospective analysis of clinical outcome in patients with pemphigus treated with high-dose IVIg adjuvant therapy
 
$75,000

2016-2017
Allergan
Characterization of recombinant SLURP-1 and SLURP-2 proteins in corneal epithelial cell culture
$54,075

2016-2017
Allergan
Extension of proof-of-concept study of inhibition of sebocyte proliferation and lipid synthesis by anti-cholinergic drugs
 
$82,843

2016-2017
UC Irvine
Elucidating the role of eosinophil degranulation proteins on the basement membrane: Identifying a direct pathogenic mechanism of eosinophils in bullous pemphigoid
 
$47,000

2015-2016
Allergan
Proof-of-concept study of inhibition of sebocyte proliferation and lipid synthesis by anti-cholinergic drugs
 
$50,000

2013-2014
Grifols Therapeutics Inc
 
Proof-Of-Concept Study Of IVIg Efficacy in Patients with Cutaneous Lupus Erythematosus
 
$219,343

2012-2014
Pfizer
Sirolimus For the Treatment of Pemphigus Vulgaris
Free drug supply

2012-2014
American Lung Association
Nicotinergic Control of Lung Cancer
$200,000

2012-2013
Department of Defense
Nicotinic Receptor Polymorphism in Lung Cancer
$115,000

2011-2012
Lung Cancer Research Foundation
Potential of Nicotinic Antagonists for Pharmacologic Control of Lung Cancer
$50,000

2010-2015
NIH, NIEHS/R01
Nicotinic Receptor Ligands and Tobacco-Induced Lung Cancer
$1,720,216

2010-2011
NIH, NIAMS/R13
Pemphigus & Pemphigoid: from the bench to the bedside
$20,000

2008-2013
NIH, NIDCR/R01
Epithelial Acetylcholine in Oral Biology and Pathology
$1,854,317

2007-2010
Institute For Science and Health/Research Grant
Receptor-mediated Mechanisms of Tobacco-Induced Lung Oncogenesis
$500,000

2006-2009
NIH, NIEHS/R21
Nicotinic receptor-mediated Action of Tobacco Nitrosamines On Bronchial Cells
$416,875

2005-2011
NIH, NIGMS/R01
Regulation of Keratinocyte Migration by Acetylcholine
$1,687,500

2005-2008
NIH, NCI/R03
Can Nicotinic Antagonists Prevent Tobacco Smoke-induced Lung Tumors in A/J Mice?
$151,500

2002-2007
NIH, NIDCR/R01
Epithelial Acetylcholine in Oral Biology and Pathology
$1,299,156

2005-2008
Flight Attendant Medical Research Institute/Research Award
Nicotinic Receptors Alter Gene Expression in Keratinocytes
$324,000

2002-2005
NIH, NIGMS/R01
Regulation of Keratinocyte Migration by Acetylcholine
$779,625

2002-2005
Flight Attendant Medical Research Institute/Research Award
Precocious Skin Aging Due to Second Hand Smoke
$325,500

2002-2005
The Robert Leet & Clara Guthrie Patterson Trust
Development of Non-steroidal Treatment of Pemphigus
$36,000

 
1999-2003
Unilever Research/Private Contract
Cholinergic Control of Skin Aging
$497,369

1998-2001
The Smokeless Tobacco Research Council-USA/Research Grant
The Cholinergic System of Oral Epithelium: Structure and Biomedical Significance
$278,340
 

1995-2002
NIH, NIAMS/R29
Cholinergic Control of Keratinocyte Migration
$499,528
 

1996-1999
Unilever Research/Private Contract
Cholinergic Networks of Young vs. Aged and Photodamaged vs. Non-photodamaged Skin
$465,450
 

1995-1998
The Council for Tobacco Research - U.S.A., Inc/Research Grant
Keratinocyte Cholinergic Receptors in Pemphigus Autoimmunity
$244,500
 

1994-1995
Minnesota Medical Foundation/Research Grant
Physiological and Pathological Significance of Keratinocyte Cholinergic Receptors
$17,500
 

1992-1993
Dermatology Foundation/Research Grant
Subtypes of Cutaneous Muscarinic Receptors
$10,000
 

1992-1993
University of Minnesota Graduate School/Research Grant
Biological Functions of Keratinocyte Cholinergic System
$8,500
 

1991-1992
Minnesota Medical Foundation/Research Grant
Keratinocyte Cholinergic System 
$7,500
 

 
As a Co-investigator:
 
2010
University of California, Cancer Research Coordinating Committee: "Genetic polymorphisms of nicotinic acetylcholine receptors that increase the risk for cancer of the cervix and other smoking related carcinomas" (PI: Hans-Ulrich Bernard, PhD)
 

2005
NIH, NIAMS/R13 " Pemphigus 2005 - Progress and Future Directions (PI: Jean-Claude Bystryn, MD

1994
NIH, NIDA/P01: "Nicotinic receptors in non-neuronal cells as targets for nicotine toxicity" (PI: Bianca M. Conti-Fine, MD)

1993
Dermatology Foundation: "Novel techniques for culturing basal cell carcinoma" (PI: Christopher B. Zachary, MBBS, FRCP)

1993
Minnesota Medical Foundation: "Reproduction of basal cell carcinoma in  nude mice" (PI: Christopher B. Zachary, MBBS, FRCP)

1991
Minnesota Medical Foundation: "Effects of mannan on keratinocyte morphology" (PI: Mark V. Dahl, MD)

 
 
 
Advisees (junior faculty/fellows/graduate and postgraduate students) in USA:
 
Sébastien de Feraudy, M.D., PhD., Associate Professor of Dermatology
Kyle Amber, MD, dermatology resident
 
Anand K. Ganesan, MD, PhD, Assistant Professor of Dermatology
Intratumoral heterogeneity during melanoma progression." University of California-Irvine (2015-2018)
 
"Role of MBP in subepidermal detachment of keratinocytes in bullous pemphigoid" University of California-Irvine (2015-2018)
NIH, NIAMS, 1K08ARO56001-01A1 “Aldehyde Dehydrogenase: A Novel Regulator of Melanin Biogenesis.” University of California-Irvine (2008-2013)
 

Annette Czernik, MD, immunodermatology fellow
"Immunoblistering dermatoses". University of California-Irvine (2009-2012)
 

Arisa Ortiz, MD, dermatology resident
"Smoking in dermatology". University of California-Irvine (2000-2012)
 

Jing Qian, PhD, postdoctoral fellow
"Cholinergic system of murine T lymphocytes.” University of California-Irvine (2008-2011)
 

Courtney Philips, medical student
"Biologic effects of sera from patients with Grover's disease" University of California-Irvine (2009-2011)
 

Vivian Gindi, MD, postdoctoral fellow
"The immunopathology of Grover's disease". University of California-Irvine (2009-2010)
 

Steve Marchenko, medical student
"Autoimmunity to new keratinocyte antigens in pemphigus". University of California-Irvine (2008-2011)
 

Vu T. Nguyen, PhD student, postdoctoral fellow
“Non-desmoglein targets of pemphigus autoimmunity” University of California-Davis (1996-2001)

Juan Arredondo, PhD, postdoctoral fellow
The role for cholinergic system of oral epithelium in mediating nicotine effects in the upper digestive tract University of California-Davis (2000-2002)
 

Leon Hall, PhD, postdoctoral fellow
“The cholinergic system of oral epithelium.”  University of California-Davis (1998-2000)
 

A. S. Sodhi, MD/PhD student
"Regulation of angiogenesis and tumorigenesis by Kaposi's sarcoma associated herpesvirus genes." HHMI-NIH (1997-2000)
 

Rico. Buchli, PhD, postdoctoral fellow
“Cholinergic enzymes and receptors of skin melanocytes and fibroblasts.”  University of California-Davis (1997-1999)
 

O. M. Memar, MD/PhD student
"The characterization of pemphigus vulgaris antigen expressed in insect cells: induction of blister-causing antibodies." The University of Texas Medical Branch at Galveston (1990-1995)
 

 
Advisees (graduate and postgraduate students/fellows) in Ukraine:
A.I. Chernyavsky, Ph.D., biochemistry/immunology fellow
"The role of serine proteases in mediating cellular cytotoxic reactions."  College of Biological Sciences at Kyiv State University, Ukraine (1990-1995)

A.I. Kurchenko, M.D., pharmacology/immunology fellow
"The immunocorrection with thymic hormone preparations in treatment of patients with eczema."  PostGraduate Institute for Physicians, Kyiv, Ukraine (1988-1992)

T.A. Korostash, Ph.D., pharmacology/cell biology fellow
"The mechanisms of action of the immunosuppressors prednisolone and doxycycline on lymphocyte subpopulations."  College of Biological Sciences at Kyiv State University, Ukraine (1986-1991)

 
External Examiner:
2009 - M.F. Vladimirsky Regional R&D Clinical Institute, Moscow, Russia; Candidate: N.V. Makhneva - Doctor of Medical Science.
2007 - University of Sheffield, Sheffield, UK; Candidate: D.J. Gawkrodger - Doctor of Science.
2006 - Palladin Institute of Biochemistry, Kyiv, Ukraine; M. Skok - Doctor of Biological Science.
2004 - University of Bradford, Bradford, UK; Candidate: S.M.A.O. Elwary - PhD.II. 
 
 
Bibliography
            Total, excluding abstracts and audio-visuals, 285 (211 in English and 74 in Russian or Ukrainian). Abstracts - 171, Audio-visuals - 5. As of 4/9/21: H-index 70; citations 13,078.
 
Books, Book Chapters, and Other Monographs
  1. Glukhenky BT, Kalyuzhnaya LD, Grando SA, Glukhenkaya AB: Comprehensive Examination and Treatment of the Patients with Atopic Dermatitis. Kyiv:  the Ukr.SSR Ministry of Health, 1982, 13 p. (In Russian).
  2.  Grando SA: Kallikrein-Kinin System and Protease Inhibitors in Atopic Dermatitis. Kyiv: KSATIP, 1984, 210 p. (In Russian).
  3.   Grando SA, Glukhenky BT, Kutsenko NS, Lastovetskaya GI, Boyko YY, Kozij LM: Comprehensive Stage-by-Stage Individualized Treatment of Patients with Autoimmune Pemphigus. Kyiv: the Ukr.SSR Ministry of Health, 1987, 15 p. (In Russian).
  4. Grando SA: Pemphigus Vulgaris and Bullous Pemphigoid: Immunopathogenesis and Individualized Treatment of Patients. Kyiv: KSATIP, 1989, 519 p. (In Russian).
  5. Glukhenky BT, Grando SA, Boiko YY et al. Reference Book on Medical Cosmetics. Kyiv: Zdorovya, 1989, 1304 p. (In Russian).       
  6. Grando SA, Glukhenky BT, Boyko YY, Kutsenko NS, Lastovetskaya GI: Immunofluorescent Diagnostics of Dermatoses. Kyiv: the Ukr.SSR Ministry of Health, 1988, 28 p. (In Russian).
  7. Glukhenky BT, Grando SA: Immune-Dependent Dermatoses: Eczema, Atopic Dermatitis, Autoimmune Pemphigus, Pemphigoids. Kyiv: Zdorovya, 1990, 478 p. (In Russian).
  8.   Turkevitch Y, Glukhenky BT, Tzhisnetskaya A, Grando SA: AIDS. Epidemiology, Clinical Picture, Diagnostics, Prevention. Kyiv: Ukr.SSR Ministry of Health, 1988, 5 p. (In Russian).
  9.  Grando AA, Grando SA: Medical Ethics (A Textbook). Kyiv: Triumph, 1994, 256 p. (In Russian).
  10. Grando SA: Autoantibodies to mucocutaneous antigens. In: Autoantibodies. 2nd Edition. Elsevier, 2007: 765-780
  11. Czernik A, Pittelkow MR, Grando SA: Paraneoplastic autoimmune multiorgan syndrome: Paraneoplastic pemphigus revisited. In: D.F Murrell (ed). Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer-Verlag Berlin Heidelberg, 2015, pp 289-297.
  12. Mannering I, Yu Y, Grando SA: Intravenous immunoglobulin: Dermatologic Uses.  In: Gaspari A, Tyring S and Kaplan D. Editors. Clinical and Basic Immunodermatology, 2nd edition, Springer, 2017 pp. 857-870
  13. Amber KT, Shiu J, Ferris K, Grando SA: Role of Intravenous Immunoglobulin in Dermatologic Disorders. In: Yamauchi P. (ed) Biologic and Systemic Agents in Dermatology. Springer International Publishing AG, 2018, Chapter 39, pp. 401-423.
  14. Lamberts A, Yale M, Grando SA, Horváth B, Zillikens D, Jonkman MF: Unmet needs in pemphigoid diseases: an international survey amongst patients, clinicians and researchers. In Lamberts A. Pemphigoid Disease: Insights in the nonbullous variant and disease management. Chapter 8, Rijksuniversiteit, Groningen 2020, pp. 133-144
 
Original Reports
  1. Grando SA: Significance of kinin production inhibition in the treatment of atopic dermatitis. In: Organization of Dermato-Venereologic Aid and Modern Approaches to Diagnostics, Treatment and Prevention of Widely Spread and Severe Professional Dermatoses (Kharkhov), 1980, pp. 161-162. (In Russian).
  2. Grando SA: Determination of kallikrein-kinin system enzymes in patients with itching dermatoses. In: Proceedings of the 51st Scientific Conference of Erevan Medical Institute, (Erevan), 1980, pp. 162-163. (In Russian).
  3. Grando SA: Some issues of the pathogenesis of itching dermatoses. Vrachebnoye Delo, 1981, No 3:106-108. (In Russian).
  4. Grando SA, Glukhenkaya AB, Ivanchenko LL: Results of local application of levamisole in children with atopic dermatitis.  Pediatriya, Akusherstvo i Ginekologiya, 1981, No 6:31. (In Ukrainian).
  5. Glukhenky BT, Grando SA: Investigation of the components of kallikrein-kinin system in patients with atopic dermatitis. Vestnik Dermatologii i Venerologii, 1982, No 6:10-12. (In Russian).
  6. Grando SA, Glukhenkaya AB: Participation of biologically active substances in pruritus emergence. A review. Soyuzmedinform (Moscow), 1982, No 5533, 7 p. (In Russian).
  7. Grando SA, Glukhenky BT, Glukhenkaya AB: Mechanisms of development of atopic dermatitis and participation of the kinin system components in the pathogenesis of the diseases. A review. Soyuzmedinform (Moscow), 1982, No 5534, 32 p. (In Russian).
  8. Glukhenky BT, Frishman MP, Lastovetskaya GI, Kalyuzhnaya LD, Kutsenko NS, Kozij LM, Boiko YY, Grando SA: The rapid method for treatment of patients with active syphilis. In: Pathogenesis and treatment of chronic skin and venereal diseases, (Kyiv), pp. 108-116. (In Russian).
  9. Glukhenky BT, Grando SA, Glukhenkaya AB: Immunoregulatory therapy in the treatment of atopic dermatitis. Soyuzmedinform (Kyiv), 1984, Vol. 1, 3 p. (In Russian).
  10. Glukhenky BT,  Grando SA, Glukhenkaya AB: Short-time diet at the first stage of treatment of allergic dermatoses. Soyuzmedinform (Kyiv), 1984, Vol. 2, 3 p. (In Russian).
  11. Glukhenky BT, Grando SA, Glukhenkaya AB: The management of atopic dermatitis Soyuzmedinform (Kyiv), 1984, Vol. 3, 3 p. (In Russian).
  12. Glukhenky BT, Grando SA: Application of aminocaproic acid to treatment of the patients with skin itching. Soyuzmedinform (Kyiv), 1984, Vol. 4, 2 p. (In Russian).
  13. Glukhenky BT, Grando SA, Bogdanovitch SN: Results of short-term alimentary relief in treatment of eczema and neurodermatitis. Vestnik Dermatologii i Venerologii, 1984, No 1:51-53. (In Russian).
  14. Glukhenky BT, Kalyuzhnaya LD, Boiko YY, Grando SA, Glukhenkaya AB: Combined examination and treatment of patients with atopic dermatitis. Vestnik Dermatologii i Venerologii, 1984, No 7:20-24. (In Russian).
  15. Glukhenky BT, Grando SA: Inhibition of the activity of biologically active substances for arresting fits of acute pruritus in atopic dermatitis. Sovetskaya Meditsina, 1985, No 9:115-117. (In Russian).
  16. Glukhenky BT, Grando SA: Application of proteinase inhibitors in patients with various clinical and morphological forms of atopic dermatitis. Vestnik Dermatologii i Venerologii, 1985, No 1:53-56. (In Russian).
  17. Grando SA: Serum protein fraction condition in patients with atopic dermatitis as shown by disc-electrophoresis in polyacrylamide gel. Dermatologiya i Venerologiya (Kyiv), 1985, Vol. 20:30-33. (In Russian).
  18. Glukhenky BT, Sivatchenko TP, Grando SA, Potzibina VV, Makarov AV, Tkhachuk LP: Functional activity of hypophysis, adrenal cortex, and pancreatic gland in patients with bullous dermatoses in the time course of combined immunosuppressive therapy. Vestnik Dermatologii i Venerologii, 1986, No 10:51-53. (In Russian).
  19. Glukhenky BT, Drannik GN, Grando SA, Glukhenkaya AB, Ivanchenko LL, Senyuk OF: Methods of sorption treatment of patients with immune-dependent dermatoses. In: Proceedings of the Annual Meeting of the USSR Academy of Medical Science Scientific Council on Dermatology and Venereology, (Kaunas), 1986, pp. 32-33. (In Russian).
  20. Glukhenky BT, Drannik GN, Grando SA, Glukhenkaya AB, Ivanchenko LL: Immunoregulatory effect of extracorporeal detoxification in patients with eczema, atopic dermatitis and dermatitis herpetiformis.  In: Proceedings of the Annual Meeting of the USSR Academy of Medical Science Scientific Council on Dermatology and Venereology, (Kaunas), 1986, pp. 33-34. (In Russian).
  21. Glukhenky BT, Grando SA, Kostromin AP, Korostash TA:  Determination of cyclic nucleotides in immunocompetent cells in some autoimmune injures of the skin. Vrachebnoye Delo, 1987, No 8:103-104. (In Russian).
  22. Grando SA, Gajduk IV: Peculiarities of immune homeostasis in patients with pemphigus and lichen ruber planus. In: Proceedings of the Y United Scientific & Technical Conference, (Vinnitza), 1987, pp. 33-35. (In Russian).
  23. Glukhenky BT, Boiko YY, Kozij LM, Lastovetskaya GI, Kutsenko NS, Grando SA, Choban VI: Comprehensive method for treatment of secondary syphilis. Dermatologiya i Venerologiya (Kyiv), 1987 Vol. 22:93-96. (In Russian).
  24. Grando SA, Gajduk IV: Secondary endocrinopathies in patients with immune-dependent dermatoses subjected to high-dosage hormone therapy.  In: Proceedings of the IX Regional Scientific Conference, (Vinnitza), 1987, pp. 15-16. (In Russian).
  25. Grando SA, Glukhenkaya AB, Ivanchenko LL, Amalyan VA: The effect of enterosorption on microcirculation indices and clinical picture in itching dermatoses. Vestnik Dermatologii i Venerologii, 1987, No 2:41-44. (In Russian).
  26. Kostromin AP, Grando SA, Chyornaya IV, Korostash TA: Changes of the activity and cyclic nucleotide levels in lymphocytes under the effect of immunosuppressors. In: Advances in Theoretical and Applied Infectious Immunology, (Moscow), 1987, pp. 62-63. (In Russian).
  27. Grando SA, Glukhenky BT, Kutsenko NS, Kostromin AP, Demidov SV: Immunopathologic aspects of autoimmune bullous dermatoses. Vrachebnoye Delo, 1987, No 9:94-97. (In Russian).
  28. Grando SA, Glukhenky BT, Romanenko AB: Endogenous proteinases and their inhibitors in the pathogenesis of pemphigus vulgaris. Vestnik Dermatologii i Venerologii, 1987, No 8:4-7. (In Russian).
  29. Kostromin AP, Demidov SV, Grando SA, Korostash TA, Borovok MI: Study of the effect of immunoregulatory medical preparations on cyclic nucleotide level and phosphodiesterase activity in lymphocytes. In: Proceedings of the Y Ukrainian Congress on Biochemistry, (Kyiv), 1987, pp. 22-23. (In Russian).
  30. Drannik GN, Montag TS, Grando SA, Pavlenko EP, Senyuk OF, Romanenko AB: Distribution of HLA-antigens in patients with immune-dependent skin diseases. Immunologiya, 1988, No 5:68-70. (In Russian).
  31. Drannik GN, Senyuk OF, Grando SA: Cell-mediated cytotoxicity in autoimmune bullous dermatoses. Immunologiya, 1988, No 4:68-71. (In Russian).
  32. Grando SA, Glukhenky BT, Kutsenko NS, Boiko YY, Lastovetskaya GI, Barabash TM: The management of patients with bullous and other immune-mediated dermatoses. Soyuzmedinform (Kyiv), 1988, Vol. 2, 3 p. (In Russian).
  33. Glukhenky BT, Grando SA: Sorption therapy and immunosuppressors in the treatment of patients with pemphigus vulgaris. Soyuzmedinform (Kyiv), 1988, Vol. 3, 3 p. (In Russian).
  34. Grando SA: Immunoregulatory activity of epidermal keratinocytes in norm and autoimmune bullous dermatoses. Soyuzmedinform (Moscow), 1988, No 15631, 23 p. (In Russian).
  35. Grando SA: Soluble mediators of immunity in lesion focus of pemphigus and pemphigoid patients. Soyuzmedinform (Moscow), 1988, No 15629, 11 p. (In Russian).
  36. Grando SA: Immuno-biochemical parallels in pemphigus and pemphigoid. Dermatologiya i Venerologiya (Kyiv), 1988, Vol. 23:63-69. (In Russian).
  37. Grando SA: Effect of hemosorption on interleukin cascade reactions under clinical and experimental conditions. Soyuzmedinform (Moscow), 1988, No 15630, 20 p. (In Russian).
  38. Grando SA: Combined immunosuppressive therapy of autoimmune bullous dermatoses. Sovetskaya Meditsina, 1988, No 2:113-115. (In Russian).
  39. Grando SA: Fixation of antibodies from patients with pemphigus vulgaris and pemphigus foliaceus in snake epidermis. Bulletin Experimentalnoj Biologii i Meditsiny, 1988, No 4:469-471. (In Russian).
  40. Glukhenky BT, Grando SA: Importance of therapeutic regulation of cellular immunity in treatment of patients with immune-dependent dermatoses. In: Proceedings of the Annual Meeting of the USSR Academy of Medical Science Scientific Council on Dermatology and Venereology, (Dushanbe), 1988, pp. 172-176. (In Russian).
  41. Grando SA: Phylogenetic study of pemphigus vulgaris, pemphigus foliaceus and bullous pemphigoid antigens. In: Proceedings of the Annual Meeting of the USSR Academy of Medical Science Scientific Council on Dermatology and Venereology, (Dushanbe), 1988, pp. 177-178. (In Russian).
  42. Grando SA, Glukhenky BT, Drannik GN, Kostromin AP: Contribution of immune cellular reactions to the pathogenesis of pemphigus vulgaris. Vestnik Dermatologii i Venerologii, 1988, No 5:14-18. (In Russian).
  43. Grando SA: Prolonged immunosuppressive therapy of patients with autoimmune bullous dermatoses. In: Proceedings of the YI Republican Scientific Conference on Immunotherapy, (Kyiv-Voroshilovgrad), 1988, pp. 55-56. (In Russian).
  44. Grando SA, Gajduk IV: Pathogenetic mechanisms of oral cavity mucous membrane damage in patients with lichen ruber planus and pemphigus vulgaris. In: Proceedings of the YI United Scientific & Technical Conference, (Vinnitza), 1988, pp. 33-34. (In Russian).
  45. Grando SA, Glukhenky BT, Kutsenko NS, Lastovetskaya GI, Boiko YY, Kozij LM: Effect of glucocorticoid therapy on the endocrine glands' activity in patients with autoimmune skin diseases. Vrachebnoye Delo, 1988, No 8:86-88. (In Russian).
  46. Grando SA, Kostromin AP, Demidov SA, Korostash TA: Comparative study of immunosuppressive effect of doxycycline and prednisolone in in vitro experiments. Antibiotiki i Khimiotherapiya (VINITI, Moscow), 1988, No 3319, pp 1-14. (In Russian).
  47. Grando SA, Gajduk IV: Endocrine status in patients with skin diseases in the course of systemic glucocorticoid therapy. In: Pathology of the Endocrine System (Vinnitza), 1988, pp. 8-9. (In Russian).
  48. Grando SA, Glukhenky BT, Romanenko AB, Chayun OA, Dolya SV: Mechanism of the therapeutic action of extracorporeal detoxification in autoimmune bullous dermatoses. Vestnik Dermatologii i Venerologii, 1988, No 7:6-11. (In Russian).
  49. Glukhenky BT, Grando SA, Glukhenkaya AB: Plasmapheresis in combined treatment of patients with atopic dermatitis, dermatitis herpetiformis and pemphigus vulgaris. In: Proceedings of the Y Republican Conference on Dermato-Venereology (Tbilisi), 1985, pp. 24-25. (In Russian).
  50. Grando SA: Disturbances of interleukin cascade reactions in pemphigus and pemphigoid and methods for their correction. Vestnik Dermatologii i Venerologii, 1989, No 9:10-13. (In Russian).
  51. Grando SA, Glukhenky BT, Kutsenko NS, Lastovetskaya GI, Boyko YY, Barabash TM, Chayun OA: Methods of individualized immunocorrection in bullous dermatoses. Dermatologiya i Venerologiya (Kyiv), 1989, Vol. 24:14-17. (In Russian).
  52. Grando SA, Glukhenky BT, Sokolov OA, Kravchenko RS, Gavrilov SV: Phylogenetic and experimental studies on the etiology of pemphigus vulgaris. Vestnik Dermatologii i Venerologii, 1989, No 4:7-9. (In Russian).
  53. Grando SA, Kostromin AP, Drannik GN, Glukhenky BT, Boiko YY, Korostash TA, Chernyavsky AI: Cytotoxic reaction registration by serine esterase activity. Laboratornoye Delo (VINITI, Moscow), 1989, No 5823, 19 p. (In Russian).
  54. Grando SA, Kostromin AP, Korostash TA, Chernyavsky AI, Senyuk OF, Drannik GN: Killer cell activity stimulating factor contained in pemphigus vulgaris blister fluid is not a product of arachidonic acid cyclooxygenase metabolism. Immunologiya, 1989, No 1:69-73. (In Russian).
  55. Terman AK, Grando SA, Stupina AS, Glukhenky BT: Early symptoms of skin ultrastructural changes in pemphigus vulgaris. Soyuzmedinform (Moscow), 1989, No 17006, 8 p. (In Russian).
  56. Glukhenky BT, Grando SA: Clinical forms of atopic neurodermatitis. Vestnik Dermatologii i Venerologii, 1990, No 4:37-42. (In Russian).
  57. Grando SA, Drannik GN: Epidermocytic factor inhibiting interleukin 1 and interleukin 2 production. Immunologiya, 1990, No 1:70-72. (In Russian).
  58. Grando SA, Drannik GN: Importance of the increased eicosanoid production in the appearance of high immunosuppressive activity of serum after hemosorption. Bulletin Experimentalnoj Biologii i Meditsiny, 1990, No 2:172-174. (In Russian).
  59. Grando SA, Glukhenky BT, Barabash TM, Zaslavsky LI, Chernyavsky AI: Pathophysiologic disorders and experimental therapy in pemphigus and pemphigoid. Vestnik Dermatologii i Venerologii, 1990, No 11:4-9. (In Russian).
  60. Grando SA, Glukhenky BT, Kostromin AP, Boiko YY, Kutsenko NS, Korostash TA: Role of the kallikrein-kinin system components in the pathogenesis of pemphigus and pemphigoid. Voprosy Meditsinskoj Khimii, 1990, No 1:23-27. (In Russian).
  61. Chernyavsky AI, Grando SA: Excretion of serine proteinases by killer cells in the I phase of cellular cytotoxic reactions. In: Current Problems of Scientific and Practical Dermato-Venereology, (Dnepropetrovsk), 1990, pp. 84-85. (In Russian).
  62. Glukhenky BT, Grando SA: Immunosuppressors in comprehensive therapy of epidermolysis bullosa, bullous and cicatrical pemphigoids. In: Proceedings of the Y Republican Conference on Dermato-Venereology (Tbilisi), 1985, pp. 30-31. (In Russian).
  63. Grando SA, Glukhenky BT, Kutsenko NS, Lastovetskaya GI, Boiko YY, Barabash TM, Chernyavsky AI: Simulation of pemphigus vulgaris in guinea pigs. Bulletin Experimentalnoj Biologii i Meditsiny, 1990, No 6:604-606. (In Russian).
  64. Grando SA, Glukhenky BT, Stupina AS, Terman AK: Ultrastructural changes in clinically intact skin of patients with pemphigus vulgaris. Vestnik Dermatologii i Venerologii, 1990, No 8:11-14. (In Russian).
  65. Glukhenky BT, Grando SA, Kolyadenko VG, Stepanenko VI, Glukhenkaya GB: History and clinical value of Nikolskiy symptom in diagnostics of bullous dermatoses. Ukr J Dermatol Venereol Cosmetol, 2003: No 4:6-12. (In Russian).
  66. Grando SA, Drannik GN, Glukhenky BT, Boyko YY, Kostromin AP, Chernyavsky AI: Interleukin cascade reaction inhibition by supernatants of the cultures of antibody-transformed human basal keratinocytes. Immunol Invest, 1988;17:567-576.
  67. Grando SA, Drannik GN, Kostromin AP, Glukhenky BT, Boiko YY, Korostash TA, Demidov SV, Senyuk OF: Serine proteinase esterolytic activity as an assay of cytotoxic reactions. J Immunol Meth, 1988;113:237-246.
  68. Grando SA: Fixation of antibodies of patients with pemphigus vulgaris and pemphigus foliaceus in the snake epidermis. Bull Exp Biol Med (New York) 1988;105:564-566.
  69. Grando SA, Glukhenky BT, Sokolov OA, Korostash TA, Chernyavsky AI: Antibodies of pemphigus foliaceus patients capable of specific binding with shedding snake epidermal antigen. Med Sci Res, 1988;16:165-166.
  70. Grando SA: Fixation of pemphigus vulgaris and foliaceus antibodies in shedding snake epidermis. Dermatologica, 1989;178:8-11.
  71. Grando SA: Occurrence of pemphigus vulgaris antigen in shedding snake epidermis. Clin Exp Dermatol, 1989;14:259-260.
  72. Grando SA, Drannik GN, Kostromin AP, Glukhenky BT, Chernyavsky AI, Korostash TA: Stimulating effect of pemphigus antibodies upon interleukin inhibitor production by normal human epidermocytes. Immunol Invest, 1989;18:1107-1120.
  73. Grando SA, Glukhenky BT, Drannik GN, Epshtein EV, Kostromin AP, Korostash TA: Mediators of inflammation in blister fluid from patients with pemphigus vulgaris and bullous pemphigoid. Arch Dermatol, 1989;125:925-930.
  74. Grando SA, Glukhenky BT, Drannik GN, Kostromin AP, Boiko YY, Senyuk OF: Autoreactive cytotoxic T lymphocytes in pemphigus and pemphigoid. Autoimmunity, 1989;3:247-260.
  75. Grando SA, Glukhenky BT, Drannik GN, Kostromin AP, Chernyavsky AI: Cytotoxic proteases in blister fluid of pemphigus and pemphigoid patients. Int J Tiss Reac, 1989;11:195-201.
  76. Grando SA, Glukhenky BT, Drannik GN, Kostromin AP, Romanenko AB: The effect of experimental haemocarboadsorption upon activity of mononuclear cells from normal and autoimmune patients. Immunology, 1989;66:138-142.
  77. Grando SA, Drannik GN, Glukhenky BT, Kostromin AP, Romanenko AB, Chayun OA, Chernyavsky AI: Clinical and laboratory evaluation of hemocarboadsorption in autoimmune bullous dermatoses. Int J Artif Organs, 1990;13:181-188.
  78. Grando SA, Vasilyev AN, Kostromin AP: Pemphigus antibodies and shedding snake serum enhance susceptibility of epidermal keratinocytes in natural cytotoxic reactions. Autoimmunity, 1990;8:9-16.
  79. Grando SA, Drannik GN: Role of increased eicosanoid production in enhanced immunosuppressive activity of serum after hemoperfusion. Bull Exp Biol Med (New York), 1990;109:214-216.
  80. Grando SA, Glukhenky BT, Kutsenko NS, Lastovetskaya GI, Boiko YY, Barabash, TM, Chernyavsky AI: An experimental model of pemphigus vulgaris in guinea pigs. Bull Exp Biol Med (New York), 1990;109:808-811.
  81. Grando SA, Glukhenky BT, Drannik GN, Kostromin AP, Chernyavsky AI, Barabash TM: Pemphigus and pemphigoid epidermocytes interfere with interleukin cascade reactions. J Clin Lab Immunol, 1990;32:137-141.
  82. Grando SA, Terman AK, Stupina AS, Glukhenky BT, Romanenko AB:   Ultrastructural study of clinically uninvolved skin of patients with pemphigus vulgaris. Clin Exp Dermatol, 1991;16:359-363.
  83. Grando SA: Development of concepts of etiology, pathogenesis and treatment of pemphigus vulgaris based on the hypothesis of atavistic origin of the disease. Medical Hypotheses, 1991;36:43-52.
  84. Grando SA: Pemphigus vulgaris: humoral and cellular mechanisms of immunopathogenesis. Facts, hypotheses and prospects. Nouv Dermatol, 1991;10:747-756.
  85. Grando SA, Hostager BS, Herron MJ, Dahl MV, Nelson RD: Binding of Trichophyton rubrum mannan to human monocytes in vitro. J Invest Dermatol, 1992;98:876-880.
  86. Grando SA, Herron MJ, Dahl MV, Nelson RD: Binding and uptake of Trichophyton rubrum mannan by human keratinocytes: a time course study. Acta Derm Venereol, 1992;72:273-276.
  87. Grando SA: Decompensation in proteinase-inhibitor system and application of proteinase inhibitors in pemphigus and pemphigoid. J Dermatol Sci, 1992;4:95-97.
  88. Grando SA, Dahl MV: Activation of keratinocyte muscarinic acetylcholine receptor reverses pemphigus acantholysis. J Eur Acad Derm Venereol, 1993;2:72-86.
  89. Grando SA: Physiology of endocrine skin interrelations. A review. J Am Acad Dermatol, 1993;28:981-992.
  90. Grando SA, Cabrera R, Hostager B, Bigliardi PL, Blake JS, Herron MJ, Dahl MV, Nelson RD: Computerized microassay of keratinocyte cell-substrate attachment and proliferation for assessing net stimulatory, inhibitory and toxic effects of compounds on non-immortalized cell lines. Skin Pharmacol, 1993;6:135-147.
  91. Grando SA: Is the keratinocyte cholinergic system altered in pemphigus? Editorial. J Eur Acad Derm Venereol, 1993;2:67-71.
  92. Grando SA, Kist DA, Qi M, Dahl MV: Human keratinocytes synthesize, secrete, and degrade acetylcholine. J Invest Dermatol, 1993;101:32-36.
  93. Grando SA, Crosby AM, Zelickson BD, Dahl MV: Agarose gel keratinocyte outgrowth system as a model of skin re-epithelization: Requirement of endogenous acetylcholine for outgrowth initiation. J Invest Dermatol, 1993;101:804-810.
  94. Dahl MV, Grando SA: Chronic dermatophytosis: What is specific about Trichophyton rubrum?  Adv Dermatol, 1994;9:97-109.
  95. Conti-Tronconi BM, McLane KE, Raftery MA, Grando SA, Protti MP: The nicotinic acetylcholine receptor: Structure and autoimmune pathology. In: CRC: Critical Reviews in Biochemistry and Molecular Biology, 1994;29:69-123.
  96. Grando SA, Zelickson BD, Kist DA, Weinshenker D, Bigliardi PL, Wendelschafer-Crabb G, Kennedy WR, Dahl MV: Keratinocyte muscarinic acetylcholine receptors: immunolocalization and partial characterization. J Invest Dermatol, 1995;104:95-100.
  97. Grando SA, Horton RM, Pereira EFR, Diethelm-Okita BM, George PM, Albuquerque EX, Conti-Fine BM: A nicotinic acetylcholine receptor regulating cell adhesion and motility is expressed in human keratinocytes. J Invest Dermatol 1995;105:774-781.
  98. Grando SA, Horton RM, Mauro TM, Kist DA, Dahl MV: Activation of keratinocyte nicotinic cholinergic receptors stimulates calcium influx and enhances cell differentiation. J Invest Dermatol 1996; 107:412-418.
  99. Grando SA, Schofield OMV, Skubitz APN, Kist DA, Zelickson BD, Zachary CB: Nodular basal cell carcinoma in vivo vs. in vitro: Establishment of pure cell cultures, cytomorphologic characteristics, ultrastructure, immunophenotype, biosynthetic activities, and generation of antisera. Arch Dermatol 1996;132:1185-1193.
  100. Grando SA, Horton RM:  The keratinocyte cholinergic system with acetylcholine as an epidermal cytotransmitter. Curr Opin Dermatol 1997: 4: 262-268.
  101. Grando SA:  Biological functions of keratinocyte cholinergic receptors. J Invest Dermatol Symp Proc 1997; 2: 41-48.
  102. Zia S, Ndoye A, Nguyen VT, Grando SA: Nicotine enhances expression of the a3, a4, a5, and a7 nicotinic receptors modulating calcium metabolism and regulating adhesion and motility of respiratory epithelial cells. Res Commun Molec Pathol Pharmacol 1997;97:243-262
  103. Nguyen VT, Lee TX, Ndoye A, Shultz LD, Pittelkow MR, Dahl MV, Lynch PJ, Grando SA: The pathophysiological significance of non-desmoglein targets of pemphigus autoimmunity. Pemphigus vulgaris and foliaceus patients develop antibodies against keratinocyte cholinergic receptors. Arch Dermatol 1998;134:971-980.
  104. Ndoye A, Buchli R, Nguyen VT, Zia S, Webber RJ, Lawry MA, Grando SA: Identification and mapping of keratinocyte muscarinic acetylcholine receptor subtypes in human epidermis. J Invest Derm 1998;111:410-416.
  105. Buchli R, Ndoye A, Rodriguez JG, Zia S, Webber RJ, Grando SA: Human skin fibroblasts express m2, m4, and m5 subtypes of muscarinic acetylcholine receptors. J Cell Biochem 1999;74:264-277.
  106. Nguyen VT, Hall LL, Gallacher G, Ndoye A, Jolkovsky DL, Webber RG, Buchli R, Grando SA: Choline acetyltransferase, acetylcholinesterase, and nicotinic acetylcholine receptors of human gingival and esophageal epithelia. J Dent Res 2000;72:939-949.
  107. Zia S, Ndoye A, Lee TX, Webber RJ, Grando SA: Receptor-mediated inhibition of keratinocyte migration by nicotine involves modulations of calcium influx and intracellular concentration. J Pharm Exp Ther 2000;293:973-981.
  108. Nguyen VT, Ndoye A, Grando SA: Pemphigus vulgaris antibody identifies pemphaxin—a novel keratinocyte annexin-like molecule binding acetylcholine. J Biol Chem 2000;275:29466-29476.
  109. Nguyen VT, Ndoye A, Grando SA: Novel human a9 acetylcholine receptor regulating keratinocyte adhesion is targeted by pemphigus vulgaris autoimmunity. Am J Pathol 2000;157:1377-1391.
  110. Grando SA, Dahl, MV: Nicotine and pemphigus. Arch Dermatol 2000;136;1269.
  111. Grando SA: Autoimmunity to keratinocyte acetylcholine receptors in pemphigus. Dermatology (Basel) 2000;201:290-295.
  112. Nguyen VT, Ndoye A, Shultz LD, Pittelkow MR, Grando SA: Antibodies against keratinocyte antigens other than desmoglein 1 and 3 can induce pemphigus vulgaris-like lesions. J Clin Invest 2000;106:1467-1479.
  113. Nguyen VT, Ndoye A,  Bassler KD, Shultz LD, Shields MC, Ruben BS, Webber RJ, Pittelkow MR, Lynch PJ, Grando SA: Classification, clinical manifestations and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome. A reappraisal of paraneoplastic pemphigus. Arch Dermatol 2001;137:193-206.
  114. Nguyen VT, Ndoye A, Hall LL, Zia S, Arredondo J, Chernyavsky AI, Kist DA, Zelickson, BD, Lawry MA, Grando SA: Programmed cell death of keratinocytes in human epidermis culminates in apoptotic secretion of a humectant upon secretagogue action of acetylcholine. J Cell Sci 2001; 114:1189-1204.
  115. Grando SA, Pittelkow MR, Shultz LD, Dmochowski M, Nguyen VT: Pemphigus: an unfolding story. J Invest Dermatol 2001;117:990-995.
  116. Grando SA: Receptor-mediated action of nicotine in human skin. Int J Dermatol 2001;40:691-693
  117. Buchli R, Ndoye A, Arredondo J, Webber RJ, Grando SA: Identification and characterization of muscarinic acetylcholine receptor subtypes expressed in human skin melanocytes. Mol Cell Biochem 2001;228:57-72.
  118. Arredondo J, Nguyen, VT, Chernyavsky AI, Jolkovsky DL, Pinkerton KE, Grando SA: A receptor-mediated mechanism of nicotine toxicity in oral keratinocytes. Lab Invest 2001;81:1653-1668.
  119. Arredondo J, Nguyen VT, Chernyavsky AI, Bercovich D, Orr-Urtreger A, Kummer W, Lips K, Vetter DE, Grando SA: Central role of a7 nicotinic receptor in differentiation of the stratified squamous epithelium. J Cell Biol 2002;159:325-336.
  120. Arredondo J, Hall LL, Ndoye A, Chernyavsky AI, Jolkovsky DL, Grando SA: Muscarinic acetylcholine receptors regulating cell cycle progression are expressed in human gingival keratinocytes. J Periodontal Res 2003;38;79–89.
  121. Arredondo J,  Nguyen VT, Chernyavsky AI, Bercovich D, Orr-Urtreger A, Vetter DE, Beaudet AL, Grando SA: Functional role of a7 nicotinic receptor in physiological control of cutaneous homeostasis. Life Sci 2003;72:2063-2067.
  122. Grando SA: Mucocutaneous cholinergic system is targeted in mustard-induced vesication. Life Sci 2003;72:2135-2144.
  123. Grando SA, Grando AA, Glukhenky BT, Doguzov V, Nguyen VT, Holubar K: History and clinical significance of mechanical symptoms in blistering dermatoses. A reappraisal. J Am Acad Dermatol 2003;48:86-92.
  124. Nguyen VT, Arredondo J, Chernyavsky A, Kitajima Y, Grando SA: Keratinocyte acetylcholine receptors regulate cell adhesion. Life Sci 2003;72:2081-2085.
  125. Chernyavsky A, Nguyen VT, Arredondo J, Wess J, Grando SA: The M4 muscarinic receptor-selective effects on keratinocyte crawling locomotion. Life Sci 2003;72:2069-2073.
  126. Arredondo J, Hall LL, Ndoye A, Nguyen, VT, Chernyavsky AI, Bercovich D, Orr-Urtreger A, Beaudet AL, Grando SA: Central role of fibroblast a3 nicotinic acetylcholine receptor in mediating cutaneous effects of nicotine. Lab Invest 2003;83:207-225.
  127. Grando SA, Kawashima K, Wessler I: The non-neuronal cholinergic system in humans. Life Sci 2003;72:2009-2012.
  128. Grando SA, Bernhard JD: "First author, second author, et int, and last author": A proposed citation system for biomedical papers. Science Editor 2003;26:122-123.
  129. Grando SA: New approaches to the treatment of pemphigus. J Invest Derm Symp Proc 2004;9:84-91.
  130. Nguyen VT, Arredondo J, Chernyavsky AI, Kitajima Y, Pittelkow MR, Grando SA: Pemphigus vulgaris IgG and methylprednisolone exhibit reciprocal effects on keratinocyte adhesion molecules. J Biol Chem 2004;279:2135-2146.
  131. Wadhera A, Grando SA: Pemphigus Vulgaris. Disease-based Module. Physicians' Information and Education Resource (PIER). On-line publication by the American College of Physicians and American Society of Internal Medicine (http://pier.acponline.org/physicians/diseases/d618/d618.html).
  132. Nguyen VT, Chernyavsky AI, Arredondo J, Bercovich D, Orr-Urtreger A, Vetter DE, Wess J, Beaudet AL, Kitajima Y, Grando SA: Synergistic control of keratinocyte adhesion through muscarinic and nicotinic acetylcholine receptor subtypes. Exp Cell Res 2004; 294: 534-549.
  133. Nguyen, VT, Arredondo J, Chernyavsky AI, Pittelkow MR, Kitajima Y, Grando SA: Pemphigus vulgaris acantholysis ameliorated by cholinergic agonists. Arch Dermatol 2004; 140: 327-334.
  134. Grando SA: How prednisolone works in pemphigus? Postepy Dermatologii i Alergologii 2004 21: 4-8.
  135. Chernyavsky AI, Arredondo J, Wess J, Karlsson E, Grando SA: Novel signaling pathways mediating reciprocal control of keratinocyte migration and wound epithelialization by M3 and M4 muscarinic receptors. J Cell Biol 2004;166: 261-72.
  136. Chernyavsky AI, Arredondo J, Marubio LM, Grando SA: Differential regulation of keratinocyte chemokinesis and chemotaxis through distinct nicotinic receptor subtypes J Cell Sci 2004;117:5665-79.
  137. Arredondo J, Chernyavsky AI, Jolkovsky DL, Marubio LM, Pinkerton KE, Beaudet AL, Grando SA: Novel Mechanism of Nicotine Toxicity: Regulation of Gene Expression through a3b2 Nicotinic Acetylcholine Receptors in Oral Keratinocytes. Am J Pathol 2005; 166: 597-613.
  138. Wadhera A, Grando SA: Bullous Pemphigoid. Disease-based Module. Physicians' Information and Education Resource (PIER). On-line publication by the American College of Physicians and American Society of Internal Medicine (http://pier.acponline.org/physicians/diseases/d1023/d1023-pdf.html)
  139. Arredondo J, Chernyavsky AI, Karaouni A, Grando SA: Novel mechanisms of target cell death and survival, and of IVIg therapeutic action in pemphigus. Am J Pathol 2005; 167: 1531-1544.
  140. Chernyavsky AI, Arredondo J, Karlsson E, Wessler I, Grando SA: The Ras/Raf-1/MEK1/ERK signaling pathway coupled to integrin expression mediates cholinergic regulation of keratinocyte directional migration. J Biol Chem 2005;280:39220–39228.
  141. Arredondo J, Chernyavsky AI, Webber RJ, Grando SA: Biological effects of SLURP-1 on human keratinocytes. J Invest Dermatol 2005;125:1236 –1241.
  142. Grando SA, Pittelkow MR, Schallreuter KU: Adrenergic and cholinergic control in cutaneous biology: physiological and clinical significance. J Invest Dermatol 2006;126:1948-65.
  143. Bystryn J-C, Grando SA: A novel explanation for acantholysis in pemphigus vulgaris –  the "Basal Cell Shrinkage” hypothesis. J Am Acad Dermatol 2006; 55:513-516.
  144. Lips KC, Brüggmann D, Pfeil U, Vollerthun R, Grando SA, Kummer W: Nicotinic acetylcholine receptors in rat and human placenta. Placenta 2005;26:735-46.
  145. Grando SA: Cholinergic control of epidermal cohesion.  Exp Dermatol 2006; 15: 265-282.
  146. Schwartz RA, Grando SA: Pemphigus exacerbators. Skinmed 2006; 5:109-110.
  147. Lips KS, Konig P, Schatzle K, Pfeil U, Krasteva G, Spies M, Haberberger RV, Grando SA, Kummer W. Coexpression and spatial association of nicotinic acetylcholine receptor subunits a7 and a10 in rat sympathetic neurons. J Mol Neurosci. 2006;30:15-6
  148. Kong J, Grando SA, Li YC: Regulation of interleukin-1 family cytokines interleukin-1, interleukin-1 receptor antagonist and interleukin-18 by 1,25-Dihydroxyvitamin D3 in primary keratinocytes. J Immunol 2006;176:3780-3787.
  149. Arredondo J, Chernyavsky AI, Grando SA: The nicotinic receptor antagonists abolish pathobiologic effects of tobacco-derived nitrosamines on BEP2D cells. Journal of Cancer Research and Clinical Oncology 2006;132:653-63.
  150. Arredondo J, Chernyavsky AI, Grando SA: Nicotinic receptors mediate tumorigenic action of tobacco-derived nitrosamines on immortalized oral epithelial cells. Cancer Biol Ther 2006; 5 511-517.
  151. Arredondo J, Chernyavsky AI, Pinkerton KE, Jolkovsky DL, Grando SA: Receptor-Mediated Tobacco Toxicity: Cooperation of the Ras/Raf-1/MEK1/ERK and JAK-2/STAT-3 pathways downstream of a7 nicotinic receptor in oral keratinocytes. FASEB J 2006; 20: 2093-2101.
  152. Arredondo J, Chernyavsky AI, Jolkovsky, DL, Webber RJ, Grando SA: SLURP-2: A novel cholinergic signaling peptide in human mucocutaneous epithelium. J Cell Physiol 2006;208:238-245
  153. Amagai M, Kitajima Y, Milner Y, Mahoney M, Gniadetski R, Ahmed AR, Bystryn JC, Hertl M, Pincelli C, Grando SA: Are desmoglein autoantibodies essential for the immunopathogenesis of pemphigus vulgaris, or just "witnesses of disease"? Viewpoint 6, Exp Dermatol 2006; 15: 815-31.
  154. Arredondo J, Chernyavsky AI, Pinkerton KE, Jolkovsky DL, Grando SA: Receptor-Mediated Tobacco Toxicity: Alterations of the NF-B expression and activity downstream of a7 nicotinic receptor in oral keratinocytes. Life Sciences 2007; 80: 2191-4.
  155. Orlov MD, Chernyavsky AI, Arredondo J, Grando SA: Synergistic actions of pemphigus vulgaris IgG, Fas-ligand and tumor necrosis factor-a during induction of basal cell shrinkage and acantholysis. Autoimmunity 2006;39:557-562.
  156. Hasse S, Paus R, Chernyavsky AI, Grando SA: Alterations of hair follicle growth and pigmentation in M4 muscarinic receptor knockout mice. Life Sciences 2007; 80: 2248-52.
  157. Grando SA: Pemphigus in the XXI Century: New life to an old story. Autoimmunity 2006;39:521-530.
  158. Arredondo J, Chernyavsky AI, Grando SA: SLURP-1 and -2 in normal, immortalized and malignant oral keratinocytes. Life Sciences 2007; 80: 2243-7.
  159. Chernyavsky AI, Arredondo J, Kitajima Y, Grando SA: Desmoglein vs. Non-desmoglein Signaling in Pemphigus Acantholysis: characterization of novel signaling pathways downstream of pemphigus vulgaris antigens. J Biol Chem 2007;282:13804-12.
  160. Grau V, Wilker S, Hartmann P, Lips KS, Grando SA, Padberg W, Fehrenbach H, Kummer W. Administration of keratinocyte growth factor (KGF) modulates the pulmonary expression of nicotinic acetylcholine receptor subunits a7, a9 and a10. Life Sciences 2007; 80: 2290-3.
  161. Biallas S, Wilker S, Lips KS, Kummer W, Grando SA, Padberg W, Grau V: Immunohistochemical detection of nicotinic acetylcholine receptor subunits  a9 and a10 in rat lung isografts and allografts. Life Sciences 2007; 80: 2286-9.
  162. Zarghooni S, Wunsch J, Bodenbenner M, Brüggmann D, Grando SA, Schwantes U, Wess J, Kummer W, Lips KS:Expressionn of muscarinic and nicotinic acetylcholine receptors in the mouse urothelium. Life Sciences 2007; 80: 2308-13.
  163. Bschleipfer T, Schukowski K, Weidner W, Grando SA, Schwantes U, Kummer W, Lips KS: Expression and distribution of cholinergic receptors in the human urothelium. Life Sciences 2007; 80: 2303-7.
  164. Billet SE, Grando SA, Pittelkow MR: Paraneoplastic autoimmune multiorgan syndrome: Review of the literature and support for a cytotoxic role in pathogenesis. Autoimmunity 2006;39:617-630.
  165. Grando SA, Kawashima K, Kirkpatrick CJ, Wessler I: Recent progress in understanding the non-neuronal cholinergic system in humans. Life Sciences 2007; 80: 2181-5.
  166. Kurzen H, Wessler I, Kirkpatrick CJ, Kawashima K, Grando SA: Extraneuronal cholinergic system of human skin. Horm Metab Res 2007;39:125-35.
  167. Song P, Sekhon HS, Arredondo J, Sauer D, Duan J, Lupo SL, Gravett C, Mark GP, Grando SA, Spindel ER: Acetylcholine functions as an autocrine growth factor in small cell lung carcinoma via activation of M3 muscarinic receptors. Cancer Res 2007;67:3936-44.
  168. Bystryn J-C, Grando SA: Reply. J Am Acad Dermatol 2007;56:891-892.
  169. Arredondo J, Chernyavsky AI, Grando SA: Overexpression of SLURP-1 and -2 alleviates the tumorigenic action of tobacco-derived nitrosamine on immortalized oral epithelial cells. Biochem Pharmacol 2007;74:1315–1319
  170. Fujii, YX, Fujigaya H, Moriwaki Y, Misawa H, Kasahara T, Grando SA, Kawashima K: Enhanced serum antigen-specific IgG1 and proinflammatory cytokine production in nicotinic acetylcholine receptor a7 subunit gene knockout mice. J Neuroimmunol 2007;189:69-74.
  171. Chernyavsky AI, Arredondo J, Vetter DE, Grando SA: Central role of a9 acetylcholine receptor in coordinating keratinocyte adhesion and motility at the initiation of epithelialization. Exp Cell Res 2007;313:3542–3555.
  172. Chernyavsky AI, Arredondo J, Piser T, Karlsson E, Grando SA: Differential coupling of M1 muscarinic and a7 nicotinic receptors to inhibition of pemphigus acantholysis. J Biol Chem 2008; 283:3401-8.
  173. Arredondo J, Chernyavsky AI, Pinkerton KE, Jolvsky D, Grando SA: Receptor-mediated tobacco toxicity: Acceleration of sequential expression of a5 and a7 nicotinic receptor subunits in oral keratinocytes exposed to cigarette smoke. FASEB J. 2008; 22:1356-68.
  174. Michael D, Grando SA: Novel mechanism for therapeutic action of IVIG in autoimmune blistering disorders. In: Nickoloff BJ, Nestle F (eds): Dermatologic Immunity. Current Directions in Autoimmunity, Karger, 2008, vol 18, pp 333-43.
  175. Grando SA: Basic and clinical aspects of non-neuronal acetylcholine: biological and clinical significance of non-canonical ligands of epithelial nicotinic acetylcholine receptors. J Pharmacol Sci 2008, 106;174–9.
  176. Chernyavsky Al, Arredondo J, Putney DJ, Marsh JS, Grando SA: Potential role for epithelial nicotinic receptors in tobacco related oral and lung cancers. J Stomatol Invest 2008, 2:5-14
  177. Hsu DK, Chernyavsky A1, Chen H-Y, Grando SA, Liu F: Endogenous galectin-3 is localized in membrane lipid rafts and regulates migration of dendritic cells. J Invest Dermatol 2009, 129:573-83.
  178. Chernyavsky Al, Arredondo J, Galitovskiy V, Qian J, Grando SA: Structure and function of the nicotinic arm of acetylcholine regulatory axis in human leukemic T cells. Int J Immunopathol Pharmacol. 2009, 22:461-72.
  179. Chernyavsky Al, Arredondo J, Qian J, Galitovskiy V, Grando SA: Coupling of ionic events to protein kinase signaling cascades upon activation of a nicotinic receptor:  Cooperative regulation of a2-integrin expression and Rho-kinase activity. J Biol Chem 2009;284:22140-8.
  180. Grando SA, Bystryn J-C, Chernyavsky AI, Frusic-Zlotkin M, Gniadecki R, Milner Y, Pittelkow MR, Pincelli C: Apoptolysis: a novel mechanism of skin blistering in pemphigus vulgaris linking the apoptotic pathways to basal cell shrinkage and suprabasal acantholysis. Exp Dermatol 2009;18: 764–70.
  181. Grando SA, Kurzen H: Cholinergic control of keratinocyte cohesion. In: Pathophysiology of the Desmosome, Eds. N Cirillo, A Lanza and F Gombos, Research Signpost, 2009, pp. 87-104
  182. Pavlou P, Rallis M, Deliconstantinos G, Papaioannou G, Grando SA: In vivo data on the influence of tobacco smoke and UV light on murine skin. Toxicol Ind Health. 2009;25:231-9.
  183. Bystryn J-C, Grando SA: The cause of acantholysis in pemphigus:  Further support for the “Basal Cell Shrinkage” hypothesis. Br J Dermatol 2009;161:702.
  184. Arredondo J, Omelchenko D, Chernyavsky AI, Skok M, Qian J, Grando SA: Functional role of the nicotinic arm of the acetylcholine regulatory axis in human B-cell lines. J Exp Pharmacol 2009:1 1–7.
  185. Chernyavsky AI, Arredondo J, Skok M, Grando SA: Auto/paracrine control of inflammatory cytokines by acetylcholine in macrophage-like U937 cells through nicotinic receptors. Int Immunopharm 2010;10:308–315.
  186. Marchenko S, Chernyavsky AI, Arredondo J, Gindi V, Grando SA: Antimitochondrial autoantibodies in pemphigus vulgaris: a missing link in disease pathophysiology. J Biol Chem 2010;285:3695-3704.
  187. Chernyavsky AI, Arredondo J, Galitovskiy V, Qian J, Grando SA: Upregulation of nuclear factor-kB expression by SLURP-1 is mediated by a7 nicotinic acetylcholine receptor and involves both ionic events and activation of protein kinases. Am J Physiol: Cell Physiol 2010; 299: C903–C911.
  188. Czernik A, Camilleri M, Pittelkow MR, Grando SA: Paraneoplastic autoimmune multiorgan syndrome: twenty years after. Int J Dermatol 2011 50:905-14.
  189. Grando SA, Holubar K, Schwartz RA: Jean-Claude Bystryn 1938-2010. An obituary. Exp Dermatol 2011;20:293-6.
  190. Kalantari-Dehagli M, Molina DM, Farhadieh M, Morrow WJ, Liang X, Felgner PL, Grando SA: New targets of pemphigus vulgaris antibodies identified by protein array technology. Exp Dermatol 2011;20:145–158.
  191. Schepotin IB, Kolesnik OO, Lukashenko AV, Mahmudov DE, Grando SA: Role of a Fast Track Surgery multimodal program in surgical treatment of colorectal cancer. Clinical Oncology 2011;2:16-20.
  192. Qian J, Galitovskiy V, Chernyavsky AI, Marchenko S, Grando SA: Plasticity of the murine T cell cholinergic receptors and their role in differentiation of naïve CD4 T cells toward the Th1, Th2 and Th17 lineages. Genes Immun 2011;12:222-30.
  193. Galitovskiy V, Qian J, Chernyavsky AI, Marchenko S, Gindi V, Edwards RA, Grando SA: Cytokine-induced alterations of a7 nicotinic receptor in colonic CD4 T cells mediate dichotomous response to nicotine in murine models of Th1/Th17 vs. Th2-mediated colitis. J Immunol 2011;187:2677-87.
  194. Koval L, Lykhmus O, Tsetlin V, Khruschov A, Magrini E, Viola A, Chernyavsky A, Qian J, Grando S, Komisarenko S, Skok M: Differential involvement of a4b2, a7 and a9a10 nicotinic acetylcholine receptors in B lymphocyte activation in vitro. Int J Biochem Cell Biol 2011: 43; 516–524.
  195. Grando SA, Laquer VT, Le HM: Sirolimus for acute pemphigus vulgaris: A case report and discussion of dualistic therapeutic activity allowing both immunosuppression and keratinocyte protection from apoptolysis. J Am Acad Dermatol 2011;65:684-6.
  196. Schultz HY, Diaz LA, Sirois DA, Werth WP, Grando SA: Generating consensus research goals and treatment strategies for pemphigus and pemphigoid. J Invest Dermatol 2011;131:1395-9.
  197. Chikova A, Grando SA: Naturally occurring variants of human a9 nicotinic receptor differentially affect bronchial cell proliferation and transformation. PLoS ONE 2011;6 (11) e27978.
  198. Craft N., Fox LP, Goldsmith LA, Tharp MD, Czernik A, Grando SA, Bernard JD: Pemphigus erythematosus. Visual Dx. 2011. October release: http://www.visualdx.com/visualdx/visualdx6/getDiagnosisText.do?moduleId=7&diagnosisId=52321.
  199. Grando SA: Muscarinic receptor agonists and antagonists: effects on keratinocyte functions. Handb Exp Pharmacol 2012;208:429-50.
  200. Cirillo N, Cozzani E, Carrozzo M, Grando SA: Urban legends: pemphigus vulgaris. Oral Diseases 2012;18:442-5.
  201. Ortiz A, Grando SA: Smoking and the skin. Int J Dermatol 2012; 51:250-62.
  202. Grando SA: Pemphigus autoimmunity: Hypotheses and realities. Autoimmunity 2012;45:7-35.
  203. Czernik A, Toosi S, Bystryn J-C, Grando SA: Intravenous immunoglobulin in the treatment of autoimmune bullous dermatoses: an update. Autoimmunity 2012;45:111-8.
  204. Chernyavsky AI, Kalantari-Dehaghi M, Phillips C, Marchenko S, Grando SA: Novel cholinergic peptides SLURP-1 and -2 regulate epithelialization of cutaneous and oral wounds. Wound Repair Regen 2012;20:103-13.
  205. Murrell DF, Daniel BS, Joly P, Borradori L, Amagai M, Hashimoto T, Caux F, Marinovic B, Sinha A, Hertl M, Bernard P, Sirois D, Cianchini G, Fairley J, Jonkman M, Pandya A, Rubenstein D, Zillikens D, Payne A, Woodley D, Zambruno G, Aoki V, Pincelli C, Diaz L, Hall RP, Meurer M, Mascaro JM, Schmidt E, Shimizu H, Zone J, Swerlick R, Culton D, Lipozencic J, Bincie B, Bystryn J-C, Grando SA, Werth VP. Consensus statement on the definitions and outcome measures for bullous pemphigoid, J Am Acad Dermatol 2012;66:479-85.
  206. Chikova A, Bernard H-U, Shchepotin IB, Grando SA: New associations of the genetic polymorphisms in nicotinic receptor genes with the risk of lung cancer. Life Sci 2012; 91: 1103-1108.
  207. Calleja-Macias I, Osann K, Remedios-Chan M, Barrera-Saldana HA, Guerrero NN, Anton-Culver H, Chikova A, Grando SA, Bernard H-U: Association of single nucleotide polymorphisms of nicotinic acetylcholine receptor subunits with cervical neoplasia. Life Sci 2012; 91: 1099-1102.
  208. Stegemann A, Sindrilaru A, Eckes B, del Rey A, Grando SA, Fiebich BL, Scharffetter-Kochanek K, Luger TA, Böhm M: Tropisetron, a serotonin antagonist, is a novel antifibrotic agent and attenuates collagen synthesis via the α7 nicotinic acetylcholine receptor. Arthritis Rheum. 2013; 65: 792-804.
  209. Galitovskiy V, Chernyavsky AI, Edwards RA, Grando SA: Muscle sarcomas and alopecia in A/J mice chronically treated with nicotine. Life Sci 2012; 91: 1109-1112. 
  210. Kalantari-Dehaghi M, Bernard H-U, Grando SA: Reciprocal effects of NNK and SLURP-1 on oncogene expression in target epithelial cells. Life Sci 2012; 91: 1122-1125.
  211. Parnell EA, Calleja-Macias IE, Kalantari M, Grando SA, Bernard H-U. Muscarinic cholinergic signaling in cervical cancer cells affects cell motility via ERK1/2 signaling. Life Sci 2012; 91: 1093-1098.
  212. Grando SA, Kawashima K, Kirkpatrick CJ, Meurs H, Wessler I: The non-neuronal cholinergic system: basic science, therapeutic implications and new perspectives. Life Sci 2012; 91: 969-972.
  213. Gordon W, Galitovskiy V, Edwards R, Andersen B, Grando SA: The tobacco carcinogen nitrosamine induces a differential gene expression response in tumor susceptible A/J and resistant C3H mouse lungs. Eur J Cancer 2013;49:3725–33.
  214. Chernyavsky AI, Marchenko S, Phillips C, Grando SA: Auto/paracrine nicotinergic peptides regulate cutaneous stress response to wounding. Dermatoendocrinology 2012; 4:324-30.
  215. Kalantari-Dehaghi M, Anhalt GJ, Camilleri MJ, Chernyavsky AI, Chun C, Leiferman KM, Felgner PL, Jasinskas A, Leiferman LM, Liang L, Marchenko S, Nakajima-Sasaki R, Pittelkow MR, Zone JJ, Grando SA: Pemphigus vulgaris autoantibody profiling by proteomic technique. PLoS ONE 2013; 8(3): e57587.
  216. Grando SA: The urgent need for randomized clinical trial of rituximab in pemphigus. Sci Transl Med http://stm.sciencemag.org/content/5/175/175ra30/reply#scitransmed_el_3004 (March 15, 2013).
  217. Kalantari-Dehaghi M, Chen Y, Deng W, Chernyavsky A, Marchenko S, Wang P, Grando SA: Mechanisms of mitochondrial damage in keratinocytes by pemphigus vulgaris antibodies. J Biol Chem 2013; 288: 16916-25.
  218. Galitovskiy V, Sevrioukov E, Corches A, Kuruvilla SK, Pan M-L, Kalantari-Dehaghi M, Chernyavsky AI, Mukherjee J, Grando SA: Development of novel approach to diagnostic imaging of lung cancer with 18F-Nifene PET/CT using A/J mice treated with NNK. J Cancer Res Therapy 2013; 1: 128-37.
  219. Phillips C, Kalantari-Dehaghi M, Gindi V, Marchenko S, Chernyavsky A, Chun S, Galitovskiy V, Paslin D, Grando SA: Is Grover's disease an autoimmune dermatosis? Exp Dermatol 2013; 22:781-4.
  220. Grando SA: Connections of nicotine to cancer. Nature Reviews Cancer 2014; 14:419-29.
  221. Chernyavsky AI, Galitovskiy V, Shchepotin IB, Grando SA: Anti-inflammatory effects of the nicotinergic peptides SLURP-1 and SLURP-2 on human intestinal epithelial cells and immunocytes. BioMed Research International 2014, Vol. 2014, Article ID 609086, 7 pages.
  222. Tang W, Kuruvilla SA, Sevrioukov E, Galitovskiy V, Pan M-L, Kalantari-Dehaghi M, Grando SA, Mukherjee J: Targeting histone deacetylase in lung cancer for early diagnosis: 18F-FAHA PET/CT imaging of NNK-treated A/J mice model. American Journal of Nuclear Medicine and Molecular Imaging 2014; 4: 324-32.
  223. Chernyavsky A, Galitovskiy V, Shchepotin IB, Jester JV, Grando SA: The acetylcholine signaling network of corneal epithelium and its role in regulation of random and directional migration of corneal epithelial cells. Invest Ophthalmol Vis Sci 2014; 55: 6921-33.
  224. Murrell DF, Marinovic B, Caux F, Prost K, Ahmed R, Wozniak K, Amagai M, Bauer J, Beissert S, Borradori L, Culton D, Fairley JA, Fivenson D, Jonkman MF, Marinkovich MP, Woodley D, Zone J, Aoki V, Bernard P, Bruckner-Tuderman L, Cianchini G, Venning V, Diaz L, Eming R, Grando SA, Hall RP, Hashimoto T, Herrero-González JE, Hertl, M, Joly P, Karpati S, Kim J, Kim SC, Korman NJ, Kowalewski C, Lee SE, Rubenstein, DR, Sprecher E, Yancey K, Zambruno G, Zillikens D, Doan S, Daniel BS, Werth VP: Definitions and outcome measures for mucous membrane pemphigoid: recommendations by an international panel of experts. J Am Acad Dermatol. 2015; 72: 168-74.
  225. He Y, Shimoda M, Ono Y, Bustos Villalobos I, Konia T, Grando SA, Zone JJ, Maverakis E: Persistence of Autoreactive IgA-Secreting B Cells Despite Multiple Immunosuppressive Medications Including Rituximab. JAMA Dermatol. 2015; 151: 646-50
  226. McMillan R, Taylor J, Shephard M, Ahmed R, Carrozzo M, Setterfield J, Grando S, Mignogna M, Kuten-Shorrer M, Musbah T, Elia A, McGowan R, Kerr A, Greenberg M, Hodgson T, Sirois D: World Workshop on Oral Medicine VI: A systematic review of the treatment of mucocutaneous pemphigus vulgaris. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;120:132-42
  227. Taylor J, McMillan R, Shephard M, Setterfield J, Ahmed R, Carrozzo M, Grando S, Mignogna M,  Kuten-Shorrer M, Musbah T, Elia A, McGowan R, Kerr AR, Greenberg MS, Hodgson T, Sirois D: World Workshop on Oral Medicine VI: a systematic review of the treatment of mucous membrane pemphigoid. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015; 120:161-71
  228. Chernyavsky A, Shchepotin IB, Galitovskiy V, Grando SA: Mechanisms of tumor-promoting activities of nicotine: Synergistic effects of cell membrane and mitochondrial nicotinic acetylcholine receptors. BMC Cancer 2015, 15:152.
  229. Ky C, Swasdibutra B, Khademi S, Desai S, Grando SA: Efficacy of IVIG monotherapy in patients with cutaneous lupus erythematosus: Results of proof-of-concept study. Dermatology Reports 2015; 7: 5804.
  230. Kalantari-Dehaghi M, Parnell E, Armand T, Bernard H-U, Grando SA: The nicotinic acetylcholine receptor-mediated reciprocal effects of the tobacco nitrosamine NNK and SLURP-1 on human mammary epithelial cells. Intl Immunopharmacol 2015; 29: 99-104.
  231. Chernyavsky A, Galitovskiy V, Grando SA: Molecular mechanisms of synergy of corneal muscarinic and nicotinic acetylcholine receptors in upregulation of E-cadherin expression. Intl Immunopharmacol 2015; 29: 15-20.
  232. Chernyavsky A, Chen Y, Wang PH, Grando SA: The mitochondrial nicotinic acetylcholine receptors targeted by pemphigus vulgaris antibodies protect keratinocytes from apoptolysis. Intl Immunopharmacol 2015; 29: 76-80.
  233. Grando SA: The mitochondrion is a common target of disease pathophysiology in pemphigus and pemphigoid. Exp Dermatol 2015; 24: 655-6.
  234. Chernyavsky A, Shchepotin IB, Grando SA: Mechanisms of growth-promoting and tumor-protecting effects of epithelial nicotinic acetylcholine receptors. Intl Immunopharmacol 2015; 29: 36-44.
  235. Grando SA, Pittelkow M: Pseudo pemphigus phenotypes in mice with inactivated desmoglein 3: Further insight to the complexity of pemphigus pathophysiology. Am J Pathol 2015, 185: 3125-7.
  236. Chen Y, Chernyavsky A, Webber R, Grando SA*, Wang PH* (*co-corresponding, co-senior authors): Critical role of FcRn in the pathogenic action of anti-mitochondrial autoantibodies synergizing with anti-desmoglein autoantibodies in pemphigus vulgaris. J Biol Chem 2015; 290: 23826-37.
  237. Grando SA, Kawashima K, Kirkpatrick CJ, Kummer W, Wessler I: Recent progress in revealing the biological and medical significance of the non-neuronal cholinergic system. Intl Immunopharmacol. 2015; 29: 1-7.
  238. Ahmed AR, Carrozzo M, Caux F, Cirillo N, Dmochowski M, España A, Gniadecki R, Hertl M, López-Zabalza MJ, Lotti R, Pincelli C, Pittelkow M, Schmidt E, Sinha AA, Sprecher E, Grando SA: Monopathogenic vs. multipathogenic explanations of pemphigus pathophysiology. Exp Dermatol 2016; 25:839-46.
  239. Amber KT, Panganiban CM, Korta D, de Feraudy S, Kelly KM, Grando SA: A case report of bullous pemphigoid associated with melanoma and a review of literature. Melanoma Research 2017; 27: 65-67.
  240. Valdebran M, Amber K, Grando SA. Cicatricial (mucous membrane) pemphigoid. Medscape Drugs & Diseases. Updated 5.3.2017. Available at: https://authoring.medscape.com/content/1062534
  241. Amber KT, Korta DZ, de Feraudy S, Grando SA: Vesiculobullous eruption in a patient receiving PUVA treatment for prurigo nodules: A case of PUVA-aggravated pemphigoid nodularis and literature review. Clin Exp Dermatol. 2017 42: 833-835.
  242. Schmidt E, Spindler V, Eming R, Amagai M, Antonicelli F, Baines J, Belheouane M, Bernard P, Borradori L, Caproni M, Di Zenzo G, Grando S, Harman K, Jonkman MF, Koga H, Ludwig R, Kowalczyk AP, Müller E, Nishie W, Pas H, Payne A, Sadik CD, Seppänen A, Setterfield J, Shimizu H, Sinha AA, Sprecher E, Sticherling M, Ujiie H, Yoshida K, Zillikens D, Hertl M, Waschke J: Meeting report of the Pathogenesis of Pemphigus and Pemphigoid Meeting in Munich, September 2016. J Invest Dermatol. 2017; 137: 1199-1203
  243. Nguyen J, Amber KT, Chapman LW, Grando SA: Pemphigus vulgaris complicated by extensive keloid scarring. Clin Exp Dermatol 2018; 43: 76-77
  244. Spindler V, Eming R, Schmidt E, Amagai M, Grando SA, Jonkman MF, Kowalczyk AP, Muller EJ, Payne AS, Pincelli C, Sinha AA, Sprecher E, Zillikens D, Hertl M, Waschke J: Mechanisms Causing Loss of Keratinocyte Cohesion in Pemphigus. J Invest Dermatol 2018; 138: 32-37.
  245. Grando SA, Zachary CB: The non-neuronal and non-muscular effects of botulinum toxin: A graceful opportunity for a deadly molecule to treat a human disease in the skin and beyond. Br J Dermatol. 2018; 178: 1011-1019.
  246. Amber KT, Valdebran M, Grando SA: Non-desmoglein antibodies in patients with pemphigus vulgaris. Frontiers in Immunology 2018; 9:1190.
  247. Amber KT, Valdebran M, Kridin K, Grando SA: The role of eosinophils in bullous pemphigoid: A developing model of eosinophil pathogenicity in mucocutaneous disease. Frontiers in Medicine. 2018; 5: 201.
  248. Amber KT, Grando SA: Current practices for the prophylaxis against bone mineral density loss in patients with autoimmune blistering disease treated with  corticosteroids: an expert survey. J Eur Acad Dermatol Venereol. 2018; 32: e416-418.
  249. Amber KT, Grando SA: Gastrointestinal prophylaxis in patients with autoimmune blistering disease treated with corticosteroids: an expert survey. Intl J Dermatol 2018; 57: e125-126.
  250. Amber KT, Valdebran M, Grando SA: Paraneoplastic autoimmune multiorgan syndrome (PAMS): beyond the single phenotype of paraneoplastic pemphigus. Autoimmunity Reviews 2018; 17: 1002-1010.
  251. Hosking AM, Elsensohn A, Makdisi J, Grando SA, de Feraudy S: Keratosis pilaris rubra with mucin deposition. J Cutaneous Pathol. J Cutan Pathol. 2018; 45: 958-961.
  252. Amber KT, Chernyavsky A, Agnoletti AF, Cozzani E, Grando SA: Mechanisms of pathogenic effects of eosinophil cationic protein and eosinophil derived neurotoxin on human keratinocytes. Exp Dermatol 2018; 27:1322-1327.
  253. Grando SA: Retrospective analysis of a single-center clinical experience toward development of curative treatment of 123 pemphigus patients with a long-term follow-up: efficacy and safety of the multidrug protocol combining intravenous immunoglobulin with the cytotoxic immunosuppressor and mitochondrion-protecting drugs. Intl J Dermatol 2019; 58:114–125.
  254. Lamberts A, Yale M, Grando SA, Horváth B, Zillikens D, Jonkman MF: Unmet needs in pemphigoid diseases: an international survey amongst patients, clinicians and researchers. Acta Dermato-Venereol 2019; 99: 224-225.
  255. Chernyavsky AI, Amber KT, Agnoletti AF, Wang C, Grando SA: Synergy among non-desmoglein antibodies contributes to the immunopathology of desmoglein antibody-negative pemphigus vulgaris. J Biol Chem 2019; 294: 4520–4528.
  256. Kneiber DB, Kowalski E, Kridin K, Yale M, Grando SA, Amber K: Gastrointestinal symptoms, gastrointestinal bleeding, and the role of diet in patients with autoimmune blistering disease: A survey of the International Pemphigus and Pemphigoid Foundation. J Eur Acad Dermatol Venereol. 2019; 33: 1935-1940
  257. Murrell DF, Peña S, Joly P, Marinovic B, Hashimoto T, Diaz LA, Sinha AA, Payne AS, Daneshpazhooh M, Eming R, Jonkman MF, Mimouni D, Borradori L, Kim SC, Yamagami J, Lehman JS, Saleh MA, Culton DA, Czernik A, Zone JJ, Fivenson D, Ujiie H, Wozniak K, Akman-Karakaş A, Bernard P, Korman NJ, Caux F, Drenovska K, Prost-Squarcioni C, Vassileva S, Feldman RJ, Cardones AR, Bauer J, Ioannides D, Jedlickova H, Palisson F, Patsatsi A, Uzun S, Yayli S, Zillikens D, Amagai M, Hertl M, Schmidt E, Aoki V, Grando SA, Shimizu H, Baum S, Cianchini G, Feliciani C, Iranzo P, Mascaró JM Jr., Kowalewski C, Hall R, Groves R, Harman KE, Marinkovich MP, Maverakis E, Werth VP: Diagnosis and Management of Pemphigus: recommendations by an International Panel of Experts. J Am Acad Dermatol. 2020; 82: 575-585.
  258. Grando SA, Kawashima K, Wessler I: A historic perspective on the current progress in elucidation of the biologic significance of non-neuronal acetylcholine. Int Immunopharmacol 2020, 81:106289.
  259. Wang C, Kraus CN, Patel K, Ganesan A, Grando SA: The “real-world” experience of dupilumab treatment of atopic dermatitis in adults: retrospective analysis of patients' charts. Int J Dermatol. 2020; 59:253-256
  260. Chernyavsky A, Patel KG, Grando SA: Mechanisms of synergy of autoantibodies to M3 muscarinic acetylcholine receptor and secretory pathway Ca2+/Mn2+-ATPase isoform 1 in patients with non-desmoglein pemphigus vulgaris. Int Immunopharmacol. 2020, 80:106149.
  261. Pavlou P, Antoniadou I, Peraki A, Vitsos A, Dallas P, Ioannou E, Roussis V, Deliconstantinos G, Grando SA, Rallis M: Protective effects of Pinus halepensis Bark Extract and Nicotine on Cigarette Smoke-induced Oxidative Stress in Keratinocytes. In Vivo 2020; 34:1835-1843.
  262. Grando SA, Rigas M, Chernyavsky A: Rationale for including intravenous immunoglobulin in the multidrug protocol of the curative treatment of pemphigus vulgaris and development of an assay predicting a disease relapse. Int Immunopharmacol 2020, 82:106385.
  263. Gualtieri B, Marzano AV, Grando S. Atypical pemphigus: autoimmunity against desmocollins and other non-desmoglein autoantigens. Ital J Dermatol Venerol. 2021, 156:134-141.
  264. Foulad DP, Rigas M, Piracha F, Gupta M, Nguyen M, Grando SA, Memon S. Transient lymphadenopathy during intravenous immunoglobulin (IVIg) in a patient with pemphigus vulgaris. Clin Case Rep. 2021 Sep 15;9(9):e04763.
  265. Chernyavsky A, Khylynskyi MM, Patel KG, Grando SA. Chronic exposure to the anti-M3 muscarinic acetylcholine receptor autoantibody in pemphigus vulgaris contributes to disease pathophysiology. J Biol Chem. 2022, 298: 101687.
  266. Stetkevich SA, Urso B, Saeed L, Hosking AM, Lee BA, Grando SA, Linden KG. Yellow urticaria: a rare phenomenon. Int J Dermatol. 2023 Apr;62(4):e225-e226.
  267. Duan J, Grando C, Liu S, Chernyavsky A, Chen J, Andersen B, Grando SA: The M3 muscarinic acetylcholine receptor promotes epidermal differentiation. J Invest Dermatol. 2022 Jul 20:S0022-202X(22)01665-7.
  268. Hutchinson D, Hosking A-M, Hong EM, Grando SA: Mitochondrial autoantibodies and the role of apoptosis in pemphigus vulgaris. Antibodies 2022, 11(3):55.
  269. Brami-Cherrier K, Chernavsky A, You H, Grando SA, Brideau-Andersen A, Sondergaard B. Botulinum Neurotoxin Type A Directly Affects Sebocytes and Modulates Oleic Acid-Induced Lipogenesis. Toxins (Basel). 2022 Oct 15;14(10):708.
  270. Foulad DP, Cirillo N, Grando SA: The role of non-neuronal acetylcholine in the autoimmune blistering disease pemphigus vulgaris. Biology 2023, 12, 354.
  271. Saeed L, Cox SV, Grando SA: Recalcitrant ocular linear IgA bullous disease in a patient with a history of stage III metastatic melanoma treated with a PD-1 inhibitor. British J Dermatol (submitted).
 
 
 
Abstracts (##1-16 are in Russian and the rest are in English)


  1. Grando SA, Bezdenezhnykh SE, Golota OV: Frequency of chronic non-specific lung diseases among populations of industrial cities. In: Problems in Hygiene and Environment, (Moscow), 1979, p. 66. (In Russian).
  2. Grando SA: Gall bladder nerves under condition of experimental gastric rejection. In: Proceedings of the All-Union Scientific Conference on Digestion Physiology and Pathology, (Odessa), 1979, p. 12. (In Russian).
  3. Glukhenky BT, Grando SA, Glukhenkaya AB: Preliminary results of the combined treatment of patients with atopic dermatitis. In: Proceedings of the Annual Scientific & Practical Conference of Kharkhov Regional Dermato-Venereologic Hospital, (Kharkhov), 1984, p. 14. (In Russian).
  4. Glukhenky BT, Boiko YY, Bratys FF, Grando SA: Prostatites as a complication of gonococcal infection. In: Problems in sexopathology and the sexual harmony, (Voroshilovgrad), 1988, pp. 102-103. (In Russian).
  5. Kurchenko AI, Grando SA: Thymogen immunocorrection in treatment of patients with eczema. In: Current Problems of Scientific and Practical Dermato-Venereology, (Dnepropetrovsk), 1990, pp. 82-83. (In Russian).
  6. Grando SA: The use of proteinase inhibitors in atopic dermatitis. In: Proceedings of the YIII All-Union Congress on Dermato-Venereology, (Moscow), 1985, Vol. 1, p. 62. (In Russian).
  7. Glukhenky BT, Lastovetskaya GI, Kalyuzhnaya LD, Kutsenko NS, Kozij LM, Boiko YY, Grando SA, Choban VI: The results of the study of immune system and liver function in patients with secondary syphilis. Clinical and laboratory follow up study. In: Proceedings of the YIII All-Union Congress on Dermato-Venereology, (Moscow), 1985, Vol. 2, p. 351. (In Russian).
  8. Grando SA, Makarov AV, Kostromin AP, Demidov SV: Pathogenetic grounds for immunosuppressive therapy of patients with autoimmune bullous dermatoses. In: Proceedings of the Y Ukrainian Congress on Dermato-Venereology, (Kharkhov), 1986, p. 95. (In Russian).
  9. Demidov SV, Kostromin AP, Khrapunov SN, Borovok MI, Kujbeda BB, Grando SA: The effect of thymus-derived preparations on the proliferation, cytotoxicity and activity of cyclic nucleotide anabolism and catabolism enzymes in spleen lymphocytes under condition of BCG vaccination. In:  Proceedings of the International Workshop on Mathematical Modeling in Immunology and Medicine, (Kyiv), 1988, p. 27. (In Russian).
  10. Glukhenky BT, Grando SA, Kostromin AP, Demidov SV, Chernyavsky AI, Makarov AV, Korostash TA: Cytotoxicity of peripheral blood mononuclear cells from elderly people against autologous epidermal keratinocytes.  In: Proceedings of the Y All-Union Congress on Gerontology and Geriatrics, 13 (Kyiv), 1988, Vol. 1, p. 154. (In Russian).
  11. Grando SA, Glukhenky BT, Kutsenko NS, Boyko YY, Lastovetskaya GI, Barabash TM: The increase of anti-epidermal-cell autoantibodies in the serum of healthy people in old age. In: Proceedings of the Y All-Union Congress on Gerontology and Geriatrics, (Kyiv), 1988, Vol. 1, p. 168. (In Russian).
  12. Grando SA, The normalization of interleukin cascade reactions due to combined hemocarboperfusion i the course of treatment of pemphigus and pemphigoid. In: Proceedings of the 1st Kyiv Municipal Scientific Conference for Inventors in Medicine, (Kyiv), 1988, Vol. 1, p. 33. (In Russian).
  13. Glukhenky BT, Grando SA, Kutsenko NS, Lastovetskaya GI, Boyko YY, Barabash TM, Gajduk IV, Korostash TA: Treatment of patients with autoimmune bullous dermatoses by means of eicosanoid metabolism correction. In: Proceedings of the 1st Kyiv Municipal Scientific Conference for Inventors in Medicine, (Kyiv), 1988, Vol. 1, p. 40. (In Russian).
  14. Grando SA, Glukhenky BT, Romanenko AB, Boyko YY, Kutsenko NS, Lastovetskaya GI: Leukotrienes and prostaglandins in bullous dermatoses. In: Proceedings of the Annual Scientific & Practical Conference of Kharkhov Regional Dermato-Venereologic Hospital, (Kharkhov), 1988, p. 25. (In Russian).
  15. Glukhenky BT, Grando SA, Korostash TA, Chernyavsky AI, Makarov AV, Chayun OA: Interleukins 1 and in patients with pemphigus and pemphigoid. In: Proceedings of the Annual Scientific & Practical Conference of Kharkhov Regional Dermato-Venereologic Hospital, (Kharkhov), 1988, p. 26. (In Russian).
  16. Glukhenky BT, Grando SA, Kutsenko NS, Lastovetskaya GI, Boiko YY, Barabash TM: Effect of hemosorption on the activity of immunocompetent cells from patients with bullous dermatoses. In: Proceedings of the YI All-Russia Congress on Dermato-Venereology, (Moscow), 1989, p. 420. (In Russian).
  17. Grando SA, Glukhenky BT: Treatment of pemphigus and pemphigoid patients with combined hemocarboadsorption followed by immunosuppressive therapy. In: Abstracts of the Combined Conference of International Society of Dermatology with the International Society of Dermatopathology. Dermatology in the Developing World, Oxford, 1988, pp. 68-69.
  18. Grando SA, Glukhenky BT, Romanenko AB, Demidov SV: Pemphigus antibody induced intercellular separation of cultivated murine epidermocytes is accompanied by change in ratio of intraepidermocytic cAMP/cGMP. In: Abstracts of the IV International Congress of Cell Biology, Ottawa: National Research Council, 1988, p. 69.
  19. Grando SA, Drannik GN, Kostromin AP, Korostash TA: Exocytosis of serine proteinases from autologous effector and target cells obtained from pemphigus vulgaris patients. In: Abstracts of the IV International Congress of Cell Biology, Ottawa: National Research Council, 1988, p. 236.
  20. Nikolaev VG, Glukhenky BT, Chayun OA, Grando SA: Immunomodulating effect of hemosorption followed by cytostatic therapy. In: Abstracts of the YI Annual Meeting of the International Society of Blood Purification, Vicenza, 1988, p. 1.
  21. Grando SA: Shedding snake serum protein (SSSP) causes expression of pemphigus vulgaris antigen in snake epidermis. J Invest Dermatol, 1989;93:300.
  22. Grando SA: Soluble putative factor of epidermal origin in pemphigus and pemphigoid inhibits interleukin cascade reactions. J Invest Dermatol, 1989;93:552.
  23. Grando SA, Glukhenky BT: Mediators of immunity in pemphigus and pemphigoid blister fluid. J Invest Dermatol, 1989;93:552.
  24. Grando SA, Glukhenky B, Romanenko A, Kutsenko N, Lastovetskaya GI, Barabash T, Kurchenko A, Korostash T, Zhukovsky V, Chernyavsky A: Decompensation of endoproteinase-inhibitor system in pemphigus vulgaris and bullous pemphigoid patients. Thromb Haemost, 1989;62:67.
  25. Grando SA: Shedding snake serum contains cytokine stimulating the expression of pemphigus antigen. J Interferon Res, 1990;10:172.
  26. Grando SA: Shedding snake serum protein interacts with epidermal keratinocytes. Clin Res, 1991;139:739.
  27. Dahl MV, Grando SA: Acetylcholine antagonizes the effects of pemphigus antibody in epidermal keratinocyte cultures. Clin Res, 1992;40:449 and J Invest Dermatol, 1992;98:588.
  28. Grando SA, Dahl MV, Bigliardi PL, Hostager BS, Herron MJ, Nelson RD: A putative muscarinic acetylcholine receptor of human epidermal keratinocytes controls cell-cell attachment and motility in vitro. Clin Res, 1992;40:450 and J Invest Dermatol, 1992;98:588.
  29. Grando SA, Kist DA, Qi M, Dahl MV: Human keratinocytes synthesize and release acetylcholine, a mediator with autocrine function. Clin Res, 1992;40:708.
  30. Grando SA, Lynch PJ: Muscarinic antagonist protects keratinocyte monolayers from morphological transformations induced by enalapril, and thiol drugs. J Invest Dermatol, 1993;100:541.
  31. Grando SA, Dahl MV: Biological functions of the keratinocyte cholinergic system. J Invest Dermatol, 1993;100:579.
  32. Crosby AM, Grando SA, Dahl MV: Agarose gel keratinocyte outgrowth system as a model of epidermal epithelization. J Invest Dermatol, 1993;100:585.
  33. Grando SA, Bigliardi PL, Dahl MV: Separation and partial characterization of keratinocyte muscarinic acetylcholine receptors. J Invest Dermatol, 1993;100:591.
  34. Zachary CB, Schofield OMV, Kist D, Grando SA: Culture of basal cell carcinoma. J Invest Dermatol, 1993;100:602.
  35. Grando SA, Bigliardi PL, Zelickson BD, Dahl MV: Location and character of keratinocyte muscarinic receptors. J Invest Dermatol, 1993;101:397.
  36. Schofield OMV, Kist DA, Skubitz APN, Zachary CB, Grando SA: Nodular basal cell carcinoma cell lines: Morphology, Immunophenotype and biosynthetic activity. J Invest Dermatol, 1993;101:439.
  37. Grando SA, Zelickson BD, Bigliardi PL, Conti-Tronconi BM: Nicotinic properties of keratinocyte cholinergic receptors. Clin Res, 1993;41:690
  38. Zachary CB, Skubitz APN, Schofield OMV, Kist DA, Grando SA: Polyclonal antisera to an immortal basal cell line recognize ectodermally-derived structures in human skin. Clin Res, 1993;41:664.
  39. Grando SA, Horton RM, Pereira ER, Zelickson BD, Albuquerque EX, Conti-Tronconi BM: Nicotinic acetylcholine receptors expressed in human keratinocytes: pharmacological, functional, and structural characterization J Invest Dermatol, 1994;102:595.
  40. Grando SA, George PM, Dahl MV, Conti-Tronconi BM: Antibody against keratinocyte nicotinic acetylcholine receptor in patient with coexistent pemphigus foliaceus, myasthenia gravis and thymoma. J Invest Dermatol, 1994;102:609.
  41. Pereira EFR, Albuquerque EX, George PG, Horton RM, Conti-Tronconi BM, Grando SA: Neuronal nicotinic receptors expressed in keratinocytes control cell adhesion and motility and are targeted by pemphigus antibodies. (24th Annual Meeting of the Society for Neuroscience, Miami Beach, Florida) Society for Neuroscience Abstracts 1994; 20:1140.
  42. Grando SA, Mauro T: Acetylcholine controls transmembrane calcium transport in human keratinocytes. J Invest Dermatol, 1995;104:592.
  43. Weinshenker D, Mauro T, Zelickson BD, Kist DA, Dahl MV, Grando SA:  A unique pharmacologic profile of the muscarinic acetylcholine receptor of human epidermal keratinocytes. J Invest Dermatol, 1995;104:657.
  44. Grando SA, Mauro T, Lee TX, Mirfakhraie K, Horton RM:  Novel human a9 acetylcholine receptor subunit, and other new members of the epidermal acetylcholine receptor family. J Invest Dermatol, 1996;106:834.
  45. Lee TX, Horton RM, Grando SA:  Cholinergic drugs stimulate chemokinesis of human epidermal keratinocytes. J Invest Dermatol, 1996;106:841.
  46. Horton RM, Lee TX, Grando SA:  Cloning of the human alpha-9 AChR subunit from normal epidermis and investigations into its physiological role. FASEB J, 1996;10:A688.
  47. Horton RM, Thuong Nguyen V, Grando SA: Survey of cholinergic receptor types expressed in cultured human keratinocytes. J Invest Dermatol, 1997;108:603.
  48. Grando SA, Lee TX, Dahl MV: Antibodies to keratinocyte cholinergic receptor in pemphigus. J Invest Dermatol, 1997;108:560.
  49. Buchli R, Ndoye A, Webber R, Grando SA: Identification of m2, m4 and m5 subtypes of muscarinic receptors in human skin fibroblasts. J Invest Dermatol, 1998;110:607, and J Dermatology Sci, 1998;16 (SUPPL. 1): S136.
  50. Ndoye A, Buchli R, Greenberg BM, Vu Thuong Nguyen, Lawry MA, Webber R, Grando SA: Localization of muscarinic cholinergic receptor subtypes in human epidermis and keratinocyte cell culture. J Invest Dermatol, 1998;110: 579, and J Dermato Sci, 1998;16 (SUPPL. 1): S107.
  51. Zia S, Buchli R, Ndoye A, Greenberg BM, Nguyen VT, Grando SA: The m4 keratinocyte muscarinic receptor regulates cell motility and modulates intracellular calcium. J Invest Dermatol, 1998;110: 545, and J Dermatol Sci, 1998;16 (SUPPL. 1): S73.
  52. Nguyen VT, Ndoye A, Shultz LD, Grando SA: Binding of pemphigus antibodies to the epidermis of mice lacking desmoglein 3. J Invest Dermatol, 1998;110: 506, and J Dermatol Sci, 1998;16 (SUPPL. 1): S35.
  53. Nguyen VT, Buchli R, Ndoye A, Grando SA. Molecular cloning and partial characterization of novel keratinocyte annexin-like molecule identified by pemphigus vulgaris antibodies. J Invest Dermatol, 1998;110: 486, and J Dermatol Sci, 1998;16 (SUPPL. 1): S14.
  54. Ndoye A, Nguyen VT, Zelickson BD, Lawry MA, Grando SA: The upward concentration gradient of free acetylcholine in human epidermis provides for its unopposed secretagouge action in the stratum granulosum: a step toward terminal differentiation.  J Invest Dermatol 1999;112:554.
  55. Nguyen VT, Bassler KD, Ndoye A,  Webber RJ, Shultz LD, Ruben BS, Grando SA: Paraneoplastic pemphigus: a combined humoral and cellular autoimmune disease. J Invest Dermatol 1999;112:568.
  56. Zia S, Ndoye A, Grando SA: Nicotine reduces keratinocyte migration distance by altering intracellular calcium levels via receptor-mediated pathway. J Invest Dermatol 1999;112:543.
  57. Nguyen VT, Ndoye A, Grando SA: A pool of disease-causing pemphigus vulgaris IgGs contains an autoantibody to pemphaxin, a calcium-dependent keratinocyte annexin-like molecule that can be upregulated by methylprednisolone. J Invest Dermatol 1999;112:264.
  58. Buchli R, Ndoye A, Grando SA: Molecular characterization and immunolocalization of muscarinic and nicotinic acetylcholine receptors in human melanocytes. J Invest Dermatol 1999;112:541.
  59. Nguyen VT, Ndoye A, Shultz LD, Grando SA: Characterization by immunoprecipitation of non-desmoglein 1 pemphigus vulgaris antibodies causing blisters in desmoglein 3-deficient mice. J Invest Dermatol 1999; 112:531.
  60. Nguyen VT, Ndoye A, Grando SA: Pemphigus vulgaris and pemphigus foliaceus IgGs produce distinct disease phenotypes in desmoglein 3 knockout mice. J Invest Dermatol 2000;114:753.
  61. Ndoye A, Nguyen VT, Hall LL, Grando SA: Secretion of humectant precursors during the granular cell-corneocyte transition: novel form of keratinocyte apoptosis. J Invest Dermatol 2000;114:796.
  62. Hall LL, Buchli R, Ndoye A, Webber RJ, Grando SA: Identification of nicotinic receptors in human skin fibroblasts and study of their role in mediating tobacco-related skin disease. J Invest Dermatol 2000;114:802.
  63. Buchli R, Ndoye A, Slominski A, Grando SA: Cholinergic control of melanogenesis. J Invest Dermatol 2000;114:859.
  64. Nguyen VT, Ndoye A, Grando SA: Absorption of non-desmoglein antibodies with rDsg-Ig-His helps explain the controversy about immunopathogenesis of pemphigus. J Invest Dermatol 2000;114:845.
  65. Nguyen VT, Arredondo J, Chernyavsky AI, Bercovich D, Orr-Urtreger A, Beaudet AL, Grando SA: Abnormalities of keratinocyte functions in the epidermis of knockout mice lacking the neuronal nicotinic acetylcholine receptor subunits a3, a7 or b4. J Invest Dermatol 2001;117:405.
  66. Arredondo A, Nguyen VT, Chernyavsky AI, Shafii M, Pinkerton KE, Grando SA: Reciprocal changes in the expressions of nicotinic acetylcholine receptors, and the cell cycle and differentiation genes can mediate pathobiologic effects of tobacco products on keratinocytes. J Invest Dermatol 2001;117:478.
  67. Nguyen VT, Vetter DE, Chernyavsky AI, Elgoyhen AB, Heinemann S, Grando SA: The physiologic control of keratinocyte adhesion involves regulation of cadherin and desmoglein expression via a9 acetylcholine receptor. J Invest Dermatol 2001;117:396.
  68. Nguyen VT, Grando SA: Novel animal model for testing anti-acantholytic treatments of pemphigus. J Invest Dermatol 2001;117:543.
  69. Grando SA: The importance of non-desmoglein targets of pemphigus autoimmunity. J Invest Dermatol 2002;118:736.
  70. Arredondo J,  Nguyen VT, Chernyavsky AI, Bercovich D, Orr-Urtreger A, Vetter DE, Beaudet AL, Grando SA: Functional role of a7 nicotinic receptor in keratinocyte differentiation. In: Non-Neuronal Acetylcholine: Signaling Pathways and Major Biological Effects in Humans. 1st Intl Symp Non-neuronal Acetylcholine, July 6, 2002, San Francisco, CA, p. 14.
  71. Nguyen VT, Arredondo J, Chernyavsky A, Kitajima Y, Grando SA: Keratinocyte acetylcholine receptors regulate cell adhesion. In: Non-Neuronal Acetylcholine: Signaling Pathways and Major Biological Effects in Humans. 1st Intl Symp Non-neuronal Acetylcholine, July 6, 2002, San Francisco, CA, p. 24.
  72. Chernyavsky A, Nguyen VT, Arredondo J, Wess J, Grando SA: The m4 muscarinic receptor-selective effects on keratinocyte crawling locomotion. In: Non-Neuronal Acetylcholine: Signaling Pathways and Major Biological Effects in Humans. 1st Intl Symp Non-neuronal Acetylcholine, July 6, 2002, San Francisco, CA, p. 15.
  73. Bercovich D, Arredondo J, Nguyen VT, Hall LL, Chernyavsky AI, Orr-Urtreger A, Kummer W, Lips K, Vetter DE, Beaudet AL, Grando SA: Nicotinic receptor knockout mice: cholinergic dysfunction in non-neuronal cells. In: Non-Neuronal Acetylcholine: Signaling Pathways and Major Biological Effects in Humans. 1st Intl Symp Non-neuronal Acetylcholine, July 6, 2002, San Francisco, CA, p. 14.
  74. Grando SA: Biological functions of non-neuronal acetylcholine in mucocutaneous epithelia. In: Non-Neuronal Acetylcholine: Signaling Pathways and Major Biological Effects in Humans. 1st Intl Symp Non-neuronal Acetylcholine, July 6, 2002, San Francisco, CA, p. 18.
  75. Arredondo J, Nguyen V, Chernyavsky A, Orr-Urtreger A, Bercovich D, Vetter DE, Beaudet AL, Grando SA: Central role for a7 nicotinic acetylcholine receptor in terminal differentiation of keratinocytes. J Invest Dermatol 2002;119:249.
  76. Grando SA, Arredondo J, Chernyavsky A, Kitajima Y, Nguyen VT: Mechanisms of pharmacologic regulation of keratinocyte adhesion by cholinergic drugs. J Invest Dermatol 2002;119:225
  77. Chernyavsky  A, Arredondo J, Nguyen VT, Ndoye A, Zia S, Wess J, Grando SA: Molecular mechanisms of stimulatory effect of M4 muscarinic acetylcholine receptor on keratinocyte migration. J Invest Dermatol 2002;119:225.
  78. Nguyen VT, Arredondo J, Chernyavsky A, Pittelkow MR, Kitajima Y, Grando SA: Pemphigus vulgaris IgG (PVIgG) and a corticosteroid exhibit reciprocal effects on keratinocyte adhesion molecules. J Invest Dermatol 2002;119:227.
  79. Grando SA: Role of the cholinergic system in skin biology and pathology. In: Abstracts of the 1st International Workshop on Cutaneous Neuroendocrinology. Hamburg, Germany, September 13-15, 2002.
  80. Arredondo J, Hall LL, Nguyen VT, Chernyavsky A, Pinkerton KE, Grando SA: Fibroblast a3 nicotinic receptor mediates cutaneous effects of tobacco smoke. J Invest Dermatol 2003;121 (1); abstr #223.
  81. Grando SA, Arredondo J, Chernyavsky A, Pittelkow MR, Kitajima Y, Nguyen VT: Cholinergic stimulation inhibits pemphigus IgG-induced acantholysis and ameliorates clinical disease in a patient with pemphigus vulgaris. J Invest Dermatol 2003;121 (1); abtsr #42.
  82. Grando SA: Mucocutaneous cholinergic system is targeted in mustard-induced vesication. In: Abstracts of the 7th Chemical Medical Defense Conference, Bundeswehr Institute of Pharmacology and Toxicology, Munich, Germany, April 9-10, 2003.
  83. Arredondo J, Chernyavsky AI, Jolkovsky DL, Marubio LM, Pinkerton KE, Beaudet AL, Grando SA: Nicotine regulates gene expression in oral keratinocytes. J Invest Dermatol 2004;122 (3) A16 (abstr #95).
  84. Grando SA, Chernyavsky AI, Arredondo J: Ability to induce keratinocyte apoptosis determines pathogenicity of pemphigus IgGs. J Invest Dermatol 2004;122 (3) A6 (abstr #35).
  85. Chernyavsky AI, Arredondo J, Marubio LM, Beaudet AL, Vetter DE, Grando SA: Differential regulation of keratinocyte chemokinesis and chemotaxis through distinct nicotinic receptor subtypes. J Invest Dermatol 2004;122 (3) A94 (abstr #559).
  86. Grando SA: Acetylcholine receptors in cutaneous biology - receptorology and therapeutic implications. In: Abstracts of the 1st International Meeting on Neurobiology of the Skin, Munster, Germany, February 13-15, 2004, p. 29.
  87. Arredondo J, Chernyavsky A1, Grando SA: Novel signaling peptides in human epidermis. J Invest Dermatol 2005;124 (4) Suppl.) A89
  88. Grando SA, Chernyavsky A1, Karaouni A, Arredondo J: Novel mechanisms of keratinocyte death and survival, and of therapeutic action of IVIg in pemphigus. J Invest Dermatol 2005;124 (4) Suppl.) A6.
  89. Hsu DK, Chernyavsky A1, Grando SA, Liu F" Galectin-3 regulates migration of macrophages and cutaneous dendritic cells. J Invest Dermatol 2005;124 (4) Suppl.) A11.
  90. Grando SA: Development of nonhormonal treatment of pemphigus. Ukr J Dermatol Venereol Cosmetolol 2005; 18: 153.
  91. Grando SA: New approaches to prevent pemphigus acantholysis. J Invest Dermatol 2005:125:1087 (Abstr. #16).
  92. Orlov MD, Chernyavsky AI, Arredondo J, Grando SA: Synergistic actions of pemphigus vulgaris (PV) IgG, Fas-ligand (Fas-L) and tumor necrosis factor-a (TNFa) during induction of basal cell shrinkage and acantholysis. J Invest Dermatol 2006:126 (4) Suppl: 10 (Abstr. #59).
  93. Arredondo J, Chernyavsky A, Pinkerton KE, Grando SA: Cooperation of the Ras/Raf-1/MEK1/ERK and JAK-2/STAT-3 pathways downstream of keratinocyte a7 nicotinic receptor. J Invest Dermatol 2006: 126 (4) Suppl: 86 (Abstr. #514).
  94. Chernyavsky A, Arredondo J, Karlsson E, Wessler I, Grando SA. Cholinergic regulation of keratinocyte directional migration is mediated by the Ras/Raf-1/MEK1/ERK signaling pathway altering integrin expression. J Invest Dermatol 2006: 126 (4) Suppl: 26 (Abstr. #152).
  95. Chernyavsky AI, Grando SA. Characterization of novel signaling pathways downstream of non-desmoglein targets of pathogenic autoantibodies in pemphigus vulgaris. J Invest Dermatol 2006:126;2352
  96. Bystryn J-C, Grando SA. The "basal cell shrinkage” hypothesis - a new explanation for acantholysis in pemphigus vulgaris. J Invest Dermatol 2006:126;2352.
  97. Grando SA: Biological significance of novel noncononical ligands of epithelial nicotinic receptors. In: Program and Abstract Book, Second International Symposium on Non-neuronal Acetylcholine, August 31- September 2, 2006, Mainz, Germany, p. 9.
  98. Arredondo J, Chernyavsky A, Pinkerton KE, Grando SA: Nicotinic receptors mediate nicotine toxicity in keratinocytes by altering gene expression and activity of STAT-3. In: Program and Abstract Book, Second International Symposium on Non-neuronal Acetylcholine, August 31- September 2, 2006, Mainz, Germany, p.16.
  99. Chernyavsky A, Arredondo J, Wessler I, Grando SA: Intracellular cholinergic signaling regulating directional migration of keratinocytes. In: Program and Abstract Book, Second International Symposium on Non-neuronal Acetylcholine, August 31- September 2, 2006, Mainz, Germany, p. 17.
  100. Biallas S, Wilker S, Lips KS, Kummer W, Grando SA, Padberg W, Grau V: Nicotinic acetylcholine receptor subunits alpha-9 and -10 in rat lung isografts and allografts. In: Program and Abstract Book, Second International Symposium on Non-neuronal Acetylcholine, August 31- September 2, 2006, Mainz, Germany, p. 23
  101. Grau V, Wilker S, Hartmann P, Lips K, Grando SA, Padberg W, Fehrenbach H, Kummer W: Exogenous keratinocyte growth factor (KGF) modulates the cholinergic system of the lung. In: Program and Abstract Book, Second International Symposium on Non-neuronal Acetylcholine, August 31- September 2, 2006, Mainz, Germany, p. 23.
  102. Zarghooni S, Wunsch J, Bodenbenner M, Brüggmann D, Grando SA, Schwantes U, Kummer  W, Lips KS: Expression of muscarinic and nicotinic acetylcholine receptors in the mouse urothelium. In: Program and Abstract Book, Second International Symposium on Non-neuronal Acetylcholine, August 31- September 2, 2006, Mainz, Germany, p. 26.
  103. Hartmann P, Lips KS, Galvis G, Biallas S, Pfeil U, Fronius M, Clauss W, Grando SA, Grau V, Kummer W. Nicotinic receptors on rat alveolar macrophages dampen ATP-induced increase in cytosolic calcium concentration. In: Program and Abstract Book, Second International Symposium on Non-neuronal Acetylcholine, August 31- September 2, 2006, Mainz, Germany, p. 28.
  104. Grando SA: Biological and clinical significance of non-neuronal acetylcholine and novel peptide ligands of epithelial nicotinic acetylcholine receptors (nAChR). J Pharmacol Sci. 2007 103 (Suppl. I): 28.
  105. Arredondo J, Chernyavsky A, Pinkerton KE, Grando SA: Autoregulation of sequential expression of nicotinic receptor subtypes associated with keratinocyte differentiation. J Invest Dermatol 2007:127 (Supp. 1): S19.
  106. Grando SA, Chernyavsky A, Arredondo J, Sato-Nagai M, Kitajima Y: Regulation of phosphorylation status of adhesion molecules in pemphigus. J Invest Dermatol 2007:127 (Supp. 1): S31.
  107. Chernyavsky A, Arredondo J, Grando SA: Signaling through a9 acetylcholine receptor is critical for initiation of keratinocyte migration. J Invest Dermatol 2007;127 (Supp. 1): S96.
  108. Grau V, Wilker S, Hartmann P, Lips K, Grando SA, Padberg W, Fehrenbach H, Kummer W: Keratinocyte growth factor modulates the cholinergic system of the lung. Am J Respir Crit Care Med 2007; 175: A280.
  109. Grando SA: Nicotinic receptors alter gene expression in keratinocytes. Flight Attendant Medical Research Institute 2007 Monograph, p. 23.
  110. Chernyavsky A, Arredondo J, Grando SA: Molecular mechanisms of pro-acantholytic effects of pemphigus autoantibodies and anti-acantholytic effects of cholinergic agonists. The Fifth UCIrvine Immunology Fair, 2007, p.32.
  111. Grando SA: Keratinocyte cholinergic system under the stress of skin wounding. In: First International Conference on Environmental Stressors in Biology and Medicine, Siena, Italy, June 4-6, 2008, p.10.
  112. Grando SA: Clinical and pathophysiological significance of non-desmoglein targets of pemphigus antibodies. In: Post IID2008 Satellite International Meeting on Autoimmune Bullous Diseases, Otsu, Japan, May 17-19, 2008, p.10.
  113. Grando SA: The muscarinic receptors in keratinocytes: Signaling pathways and biologic effects. In: Speakers Abstracts, Recent Advances in Muscarinic Receptors, Pharmacology & Therapeutics, An ASPET Colloquium, San Diego, April 4-5, 2008.
  114. Chernyavsky A, Arredondo J, Qian J, Galitovskiy V, Grando S: Novel mechanism of downstream signaling from keratinocyte nicotinic receptors. J Invest Dermatol 2009;129 (Suppl. 1):S91.
  115. Chernyavsky A, Arredondo J, Grando S: A desmoglein 3 pemphigus antibody signaling. J Invest Dermatol 2009;129 (Suppl. 1):S11.
  116. Qian J, Chernyavsky A, Galitovskiy V, Grando S: Plasticity of the T cell cholinergic system. J Invest Dermatol 2009;129 (Suppl. 1):S108.
  117. Galitovskiy V, Qian J, Chernyavsky AI, Marchenko S, Gindi V, Edwards RA, Grando SA: Possible explanation of the dichotomous effect of nicotine on ulcerative colitis and Crohn's disease: A role for Foxp3 T cells. The 7th UCIrvine Immunology Fair, 2009, p.23.
  118. Qian J, Galitovskiy V, Chernyavsky AI, Marchenko S, Grando SA: Plasticity of the murine T cell cholinergic receptors and their role in differentiation of CD4 cells toward the Th1 and Th2 lineages. The 7th UCIrvine Immunology Fair, 2009, p.24.
  119. Grando S: Cutaneous cholinergic system: lessons for skin pigmentary system. Pigment Cell & Melanoma Rese 2009, 22:495.
  120. Chernyavsky A, Qian J, Grando S: Upregulation of nuclear factor-B expression by SLURP-1 via keratinocyte a7 nicotinic acetylcholine receptor (nAChR) involves both ionic events and activation of protein kinases. J Invest Dermatol 2010;130 (Suppl. 1):S96.
  121. Marchenko S, Chernyavsky AI, Arredondo J, Gindi V, Grando SA: Antimitochondrial autoantibodies in pemphigus vulgaris: a missing link in disease pathophysiology. J Invest Dermatol 2010;130 (Suppl. 1):S7.
  122. Kalantari M, Molina DM, Farhadieh M, Vigil A, Morrow WJ, Liang X, Felgner PL, Grando SA: Partial evaluation of pemphigus vulgaris autoantibody profile using the protein array technology. J Invest Dermatol 2010;130 (Suppl. 1):S21.
  123. Grando SA: Smoking and skin cancers. In 13th World Congress on Cancers of the Skin. Proceedings Book, 2010, p. 43.
  124. Kalantari M, Grando S, Felgner P: New targets of pemphigus vulgaris antibodies identified by protein array technology. In JC Bystryn Pemphigus & Pemphigoid Meeting: From the Bench to the Bedside, Bethesda, November  5 and 6, 2010, p.12.
  125. Marchenko S, Chernyavsky A, Grando S: Mechanism of activation of intrinsic apoptotic pathway by pemphigus antibodies. In JC Bystryn Pemphigus & Pemphigoid Meeting: From the Bench to the Bedside, November  5 and 6, 2010, p.11.
  126. Galitovskiy V, Qian J, Chernyavsky AI, Edwards RA, Grando SA: Opposite effects of nicotine on two different murine models of bowel disease. The 8th UCIrvine Immunology Fair, 2010, p.26.
  127. Grando SA: Anti-tumorigenic effects of small cholinergic peptides of the Ly6 protein family. In: The 3rd International Conference on Drug Discovery & Therapy. Current Medicinal Chemistry (Special Issue, Abstracts), 2011, p. 23.
  128. Grando SA: Smoking is not sexy - It makes your skin look old. In: The 9th Anti-aging Medicine World Congress & Medispa. Official Congress Book, 2011, pp. 76-77
  129. Phillips C, Gindi V, Marchenko S, Chernyavsky A, Galitovkiy V, Paslin D, Grando SA: Autoimmune Component of Grover’s Disease. J Invest Dermatol 2011;131 (Suppl. 1):S11.
  130. Chernyavsky AI, Kalantari-Dehaghi M, Phillips C, Marchenko S, Grando SA: Regulation of keratinocyte migration and cutaneous wound epithelialization by cholinergic peptides involves modulation of integrin expression. J Invest Dermatol 2011;131 (Suppl. 1):S131.
  131. M. Kalantari-Dehaghi, Anhalt GJ, Camilleri MJ, Leiferman KM, Marchenko S, Pittelkow MR, Zone JJ, Grando SA: Pemphigus vulgaris antibodies target PERP and several other keratinocyte membrane and mitochondrial proteins. J Invest Dermatol 2011;131 (Suppl. 1):S11.
  132. Tang W, Galitovskiy V, Sevrioukov E, Pan ML, Constantinescu C, Grando S, Mukherjee J. 18F-FAHA PET for imaging histone deacetylase in lung cancer. J Nucl Med 2011; 52 (Suppl):411.
  133. Galitovskiy V, Sevrioukov E, Corches A, Pan ML, Constantinescu C, Grando S, Mukherjee J. 18F-Nifene PET for early diagnosis of lung cancer. J Nucl Med 2011; 52 (Suppl):1578
  134. Chikova AK, Grando SA Possible role of the nicotinic acetylcholine receptor alpha9 in lung cancer. Proc Am Assoc Cancer Res. 2011; 52:916
  135. Grando SA: The non-neuronal nicotinergic signaling network. In: Nicotinic acetylcholine receptors. A Wellcome Trust Scientific Conference. 18-21 May, 2011, T11.
  136. Phillips C, Gindi V, Marchenko S, Chernyavsky A, Galitovkiy V, Paslin D, Grando SA: Autoimmune Component of Grover’s Disease. In: 1st UC Irvine SOM Clinical, Basic & Translational Science Festival, May 24, 2011; p. 91.
  137. M. Kalantari-Dehaghi, Anhalt GJ, Camilleri MJ, Leiferman KM, Marchenko S, Pittelkow MR, Zone JJ, Grando SA: Pemphigus vulgaris antibodies target PERP and several other keratinocyte membrane and mitochondrial proteins. In: 1st UC Irvine SOM Clinical, Basic & Translational Science Festival, May 24, 2011; p. 92.
  138. Kalantari M, Molina DM, Farhadieh M, Vigil A, Morrow WJ, Liang X, Felgner PL, Grando SA: Partial evaluation of pemphigus vulgaris autoantibody profile using the protein array technology. In: 1st UC Irvine SOM Clinical, Basic & Translational Science Festival, May 24, 2011; p. 93.
  139. Marchenko S, Chernyavsky AI, Arredondo J, Gindi V, Grando SA: Antimitochondrial autoantibodies in pemphigus. In: 1st UC Irvine SOM Clinical, Basic & Translational Science Festival, May 24, 2011; p. 94.
  140. Chernyavsky A, Qian J, Grando S: Upregulation of nuclear factor-B expression by SLURP-1 via keratinocyte a7 nicotinic acetylcholine receptor (nAChR) involves both ionic events and activation of protein kinases. In: 1st UC Irvine SOM Clinical, Basic & Translational Science Festival, May 24, 2011; p. 95.
  141. Chernyavsky AI, Kalantari-Dehaghi M, Phillips C, Marchenko S, Grando SA: Regulation of keratinocyte migration and cutaneous wound epithelialization by cholinergic peptides involves modulation of integrin expression. In: 1st UC Irvine SOM Clinical, Basic & Translational Science Festival, May 24, 2011; p. 96.
  142. Chikova A, Bernard HU, Grando SA: Association of the rs8040868 variant of CHRNA3 gene encoding α3 nicotinic receptor subunit with increased risk of lung cancer. Third International Symposium on Non-neuronal Acetylcholine. The Auto/Paracrine Function of Non-neuronal Acetylcholine: Basic Science and Therapeutic Implications. August 24-26, 2011, University of Groningen, The Netherlands, 2011, p. 15.
  143. Chikova A, Grando SA: Isoforms of CHRNA9 mRNA and their influence on cellular proliferation and transformation. Third International Symposium on Non-neuronal Acetylcholine. The Auto/Paracrine Function of Non-neuronal Acetylcholine: Basic Science and Therapeutic Implications. August 24-26, 2011, University of Groningen, The Netherlands, 2011, p 17.
  144. Galitovskiy V, Edwards RE, Grando SA: Chronic administration of nicotine causes muscle neoplasia in mice. Third International Symposium on Non-neuronal Acetylcholine. The Auto/Paracrine Function of Non-neuronal Acetylcholine: Basic Science and Therapeutic Implications. August 24-26, 2011, University of Groningen, The Netherlands, 2011, p 20.
  145. Chikova A, Grando SA: Ethnic-specific polymorphisms in CHRNA3 and CHRNA9 genes. Third International Symposium on Non-neuronal Acetylcholine. The Auto/Paracrine Function of Non-neuronal Acetylcholine: Basic Science and Therapeutic Implications. August 24-26, 2011, University of Groningen, The Netherlands, 2011, p. 20.
  146. Kalantari-Dehaghi M, Bernard HU, Grando SA: Reciprocal effects of NNK and SLURP-1 on gene expression in target epithelial cells. Third International Symposium on Non-neuronal Acetylcholine. The Auto/Paracrine Function of Non-neuronal Acetylcholine: Basic Science and Therapeutic Implications. August 24-26, 2011, University of Groningen, The Netherlands, 2011, p. 22.
  147. Chikova A, Grando SA: Naturally occurring variants of human a9 nicotinic receptor differentially affect bronchial cell proliferation and transformation. Proc Am Assoc Cancer Res 2012, 53:265 (abstr. #1084).
  148. Grando S: PAMS - What's new? Programme & Exhibitor Book. 3rd Continental Congress of the International Society of Dermatology. Durban, South Africa, 24-27 October, 2012. p.54.
  149. Grando SA, Galitovskiy V, Chernyavsky AI: Anti-inflammatory activities of endogenous nicotinergic peptides in experimental models of inflammatory bowel disease. Siriraj Med J 2012; 6 (Suppl. 2): 94.
  150. Chikova A, Grando S. Ethnic-specific polymorphisms in CHRNA3 and CHRNA9 genes. Proc Am Assoc Cancer Res 2013, 54 (abstr. #1331).
  151. Grando SA: Role of non-desmoglein specific autoantibodies in pemphigus. International Pre IID 2013 Meeting on Autoimmune Bullous Diseases, May 6th and 7th, 2013, Luebeck, Germany, p. 16.
  152. Stegemann A, Sindrilaru2 A, Grando SA, Scharffetter-Kochanek K, Luger TA, Böhm M: The α7 nicotinic acetylcholine receptor – An emerging target for anti-inflammatory and antifibrotic treatment strategies in dermatology. J Invest Dermatol 2013, 133 (Suppl.1):S19 (abstr #109).
  153. Kalantari-Dehaghi M, Chen Y, Deng W, Wang PH, Grando SA: Mechanisms of keratinocyte mitochondrial damage in pemphigus vulgaris. J Invest Dermatol 2013, 133 (Suppl.1):S20 (abstr #115).
  154. Kalantari-Dehaghi M, Anhalt G, Camilleri M, Felgner P, Leiferman K, Pittelkow M, Zone J, Grando S: Pemphigus vulgaris autoantibody profiling by proteomic technique. J Invest Dermatol 2013, 133 (Suppl.1):S20 (abstr #116).
  155. Grando SA: Role of anti-mitochondrial antibodies in pemphigus autoimmunity. J Clin Cell Immunol 2013, 4, 5:28.
  156. Grando SA: Current concepts in the pathogenesis of pemphigus vulgaris. In: 9th International Congress on Autoimmunity, Nice, France, March 26-30, PS46 - Autoimmunity in Dermatology, Abstract #331.
  157. Grando SA: Modern perspectives on pemphigus autoimmunity and treatment. In: The 4th Annual Meeting of Euro-Asian Association of Dermatovenereologists, April 9-11, Jerusalem, Israel. Program & Book of Abstracts, p.40
  158. Chernyavsky A, Galitovskiy V, Grando SA: Nicotinic acetylcholine receptor (nAChR)-mediated cooperation of SLURP-2 and pro-epithelialization growth factors. J Invest Dermatol 2014, 134 (Suppl.1):S133 (abstr #760).
  159. Grando SA, Marchenko S, Galitovskiy V, Chernyavsky A: Synergy of nicotinergic peptides and growth factors in regulation of epidermal barrier repair. In: ESDR 2014 Satellite Meeting Dermatoendocrinology, September 10, 2014, 09:00-12:30, Copenhagen, p. 5.
  160. Chernyavsky A, Galitovskiy V, Jester JV, Grando SA: The acetylcholine signaling network of the corneal epithelium in norm and re-epithelialization of corneal defects. In: ESDR 2014 Satellite Meeting Dermatoendocrinology, September 10, 2014, 09:00-12:30, Copenhagen, p. 5-6.
  161. Grando SA: A pemphigus paradigm: new role for FcRn as a delivery vehicle for autoantibodies to intracellular self-antigens. In: The 10th International Congress on Autoimmunity, Leipzig, Germany, 6-10 April 2016. PS23-Parallel session 23: Autoimmunity In Dermatology. Abstract #173.
  162. Grando SA: Cutaneous non-neuronal cholinergic system. In: The XVth International Symposium on Cholinergic Mechanisms. 16-20 October 2016, Marseille, France, Abstract L19, p.34
  163. Grando SA: Connections of nicotine to cancer and its influence on cancer treatment. Abstracts of IASLC 17th World Conference of Lung Cancer, December 4-7, 2016, Vienna, Austria. J Thoracic Oncol 2017;12 (S1): S47.
  164. Grando SA: Cutaneous non-neuronal cholinergic system. J Neurochem, 2017, 142 (Suppl. 2): 191.
  165. Grando SA: The non-neuronal effects of botulinum toxin: A novel paradigm of treating human disease with deadly neurotoxins. In: "Neurotransmitters: non-neuronal functions and therapeutic opportunities", March 26-28, 2018, Orleans, France, p. 18
  166. Amber K, Agnoletti AF, Chernyavsky A, Grando S: Eosinophil major basic protein has a concentration-dependent cytotoxic effect on cultured keratinocytes. J Invest Dermatol 2017, 137, A615.
  167. Lamberts A, Yale M, Grando SA, HorváthB, Zillikens D, Jonkman MF: Unmet needs in pemphigoid diseases: an international survey amongst patients, clinicians and researchers. International Investigative Dermatology, Orlando, 2018
  168. Grando SA: Rare variants of bullous autoimmune diseases and their target antigens. EADV 2018; Paris, D1T09.4C
  169. Kneiber DB, Kowalski E, Kridin K, Yale M, Grando SA, Amber K: The role of diet in patients with autoimmune blistering disease: A survey of the International Pemphigus and Pemphigoid Foundation. J Invest Dermatol 2019; 139 (Suppl.1): S104, Abstr, #606.
  170. Amber KT, Chernyavsky A, Agnoletti A, Wang C, Grando SA: Pathophysiology of non-desmoglein antibody-negative pemphigus vulgaris. J Invest Dermatol 2019; 139 (Suppl.1): S2, Abstr, #9.
  171. Grando SA: Non-neuronal acetylcholine: a historical overview. In: 5th International Symposium on Non-neuronal Acetylcholine: from bench to bedside. September 27-29, 2019, Hyatt Regency, Long Beach, CA, USA, p. 8.
 
 
Audio-visual
1. Grando SA: Paraneoplastic autoimmune multiorgan syndrome (PAMS). Dialogues in Dermatology, American Academy of Dermatology, 2004; vol 54, No.1
2. Grando SA: Smoking and the skin. Dialogues in Dermatology, American Academy of Dermatology, 2011; vol. 67, No.12.
3. Grando SA: The epidermis and blistering disorders: pemphigus, in Tobin, D.J. (ed.), Skin Biology, The Biomedical & Life Sciences Collection, Henry Stewart Talks Ltd, London, 2014, (online at http://hstalks.com/?t=BL1813597-Grando).
4. Grando SA: The popularity of e-cigarettes and issues with nicotine. The Video Journal of Oncology, 2016 (http://www.vjoncology.com/video/9nj8llapkyq-the-popularity-of-e-cigarettes-and-issues-with-nicotine).
5. Grando SA: The role of nicotine in cancer and its impact on therapy, The Video Journal of Oncology, 2016 (http://www.vjoncology.com/video/s2ry8fviaaa-the-role-of-nicotine-in-cancer-and-its-impact-on-therapy).
6. Korman NJ, Werth V, Grando S, Sinha A: Closer Look at Pemphigus Vulgaris: Clinical Challenges and Emerging Treatments, MedScape, 12/7/2017) (https://www.medscape.org/viewarticle/883002



  • Home
  • Symposia
    • San Diego Dermatology Symposium
    • Dermatology Refresher Symposium for NPs and PAs
    • Dermatology Innovation Symposium
    • Dermatology Therapeutics Symposium
  • Archives
  • Contact Us